[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 746
1. Cimentepe E, Bayrak O, Unsal A, Koç A, Ataoğlu O, Balbay MD: Urethral adenocarcinoma mimicking urethral caruncle. Int Urogynecol J Pelvic Floor Dysfunct; 2006 Jan;17(1):96-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Urethral adenocarcinoma mimicking urethral caruncle.
  • We are presenting a 57-year-old female patient with a urethral lesion that looks like caruncle, but histopathologic examination of the excised lesion was reported as urethral adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / diagnosis. Urethral Neoplasms / diagnosis
  • [MeSH-minor] Comorbidity. Female. Humans. Middle Aged. Urinary Bladder Diseases / epidemiology. Urinary Bladder Diseases / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Gynecol Obstet. 1960 Jun;110:723-33 [14421527.001]
  • [Cites] Gynecol Obstet Invest. 1996;42(4):279-80 [8979105.001]
  • [Cites] Scand J Urol Nephrol. 1993;27(1):125-6 [8388121.001]
  • [Cites] Gynecol Oncol. 1993 Sep;50(3):389-93 [8406208.001]
  • [Cites] J Urol. 1993 Dec;150(6):1911-4 [8230535.001]
  • (PMID = 15834509.001).
  • [Journal-full-title] International urogynecology journal and pelvic floor dysfunction
  • [ISO-abbreviation] Int Urogynecol J Pelvic Floor Dysfunct
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


2. Adhikari RC, Tuladhar A, Shrestha S, Sharma SK: Deep-seated thoracic and abdominal lesions: usefulness of ultrasound guided fine needle aspiration cytology, a 3 year experience. Nepal Med Coll J; 2010 Mar;12(1):20-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These included liver (125 cases), lung (81 cases), abdominal and mediastinal lymph nodes (29 cases), ovary (14 cases), omentum (12 cases), pancreas (10 cases), kidney (10 cases), mediastinum (8 cases), gall bladder (8 cases) etc.
  • The aim of this study was to evaluate the overall utility of ultrasonographic guided FNAC in the diagnosis of abdominal and thoracic lesions.
  • In 264 cases (82.5%), FNAC was diagnostic with commonest diagnosis being malignant neoplasm (70.0%).
  • In liver, Metastatic adenocarcinoma is the commonest tumor, while in lung; the commonest lesion is non-small cell carcinoma.
  • [MeSH-major] Neoplasms / diagnosis. Ultrasonography, Interventional

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20677604.001).
  • [Journal-full-title] Nepal Medical College journal : NMCJ
  • [ISO-abbreviation] Nepal Med Coll J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Nepal
  •  go-up   go-down


3. Jasperson KW, Blazer KR, Lowstuter K, Weitzel JN: Working through a diagnostic challenge: colonic polyposis, Amsterdam criteria, and a mismatch repair mutation. Fam Cancer; 2008;7(4):281-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The two most common causes of hereditary colorectal cancer are Lynch syndrome and familial adenomatous polyposis (FAP).
  • The phenotype of Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), is differentiated in part from FAP by the lack of profuse colonic polyposis.
  • Here we describe a proband who presented with greater than 50 adenomatous colonic polyps prior to developing cancer of the colon and urinary bladder, and a family history that fulfills the Amsterdam criteria.
  • Germline analyses of APC and MYH in the proband did not reveal any mutations.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenomatous Polyposis Coli / complications. Colonic Neoplasms / genetics. Colorectal Neoplasms, Hereditary Nonpolyposis / diagnosis. DNA-Binding Proteins
  • [MeSH-minor] Carcinoma, Transitional Cell / diagnosis. Carcinoma, Transitional Cell / genetics. Female. Genes, APC. Germ-Line Mutation. Humans. Middle Aged. Neoplasms, Multiple Primary / genetics. Pedigree. Phenotype. Urinary Bladder Neoplasms / genetics

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Gastroenterol. 2002 Jul;97(7):1822-7 [12135043.001]
  • [Cites] Clin Genet. 1998 Oct;54(4):368-70 [9831355.001]
  • [Cites] Gut. 1997 Aug;41(2):235-8 [9301504.001]
  • [Cites] Gene. 2001 Jul 11;272(1-2):301-13 [11470537.001]
  • [Cites] Gastroenterology. 1999 Jun;116(6):1453-6 [10348829.001]
  • [Cites] Gastroenterology. 2004 Jan;126(1):42-8 [14699485.001]
  • [Cites] Hum Mol Genet. 2001 Apr;10(7):721-33 [11257105.001]
  • [Cites] Hum Mutat. 2004 Mar;23(3):285 [14974087.001]
  • [Cites] Int J Cancer. 2006 Aug 15;119(4):807-14 [16557584.001]
  • [Cites] Int J Colorectal Dis. 2006 Jan;21(1):79-83 [16676398.001]
  • [Cites] J Med Genet. 1999 Oct;36(10 ):790-3 [10528862.001]
  • [Cites] Dis Colon Rectum. 1991 May;34(5):424-5 [2022152.001]
  • [Cites] Int J Colorectal Dis. 2006 Dec;21(8):847-50 [16525781.001]
  • [Cites] J Bacteriol. 1994 Sep;176(17):5393-400 [8071216.001]
  • [Cites] Hum Genet. 2006 Mar;119(1-2):206-11 [16408224.001]
  • [Cites] Gut. 2003 Jun;52(6):898-9 [12740349.001]
  • [Cites] Fam Cancer. 2007;6(1):43-51 [17039270.001]
  • [Cites] Fam Cancer. 2003;2(1):43-55 [14574166.001]
  • [Cites] Clin Gastroenterol Hepatol. 2005 Oct;3(10):1022-8 [16234049.001]
  • [Cites] J Biol Chem. 2002 Mar 29;277(13):11135-42 [11801590.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 May 13;100(10):5908-13 [12732731.001]
  • [Cites] Int J Cancer. 2002 Feb 10;97(5):643-8 [11807791.001]
  • (PMID = 18176851.001).
  • [ISSN] 1389-9600
  • [Journal-full-title] Familial cancer
  • [ISO-abbreviation] Fam. Cancer
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / M01 RR000043; United States / NCI NIH HHS / CA / R25 CA085771; United States / NCRR NIH HHS / RR / M01 RR00043; United States / NCI NIH HHS / CA / R25 CA85771
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / G-T mismatch-binding protein
  •  go-up   go-down


Advertisement
4. Ihedioha U, Leung E, Chung L, Burgess G, Hendry D, O'dwyer PJ: A complex fistula caused by an eroding pelvic mesh sling. Hernia; 2007 Feb;11(1):75-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Intestinal Fistula / etiology. Postoperative Complications. Prosthesis Failure. Surgical Mesh / adverse effects. Urinary Bladder Fistula / etiology
  • [MeSH-minor] Adenocarcinoma / surgery. Humans. Male. Middle Aged. Rectal Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hernia. 2004 May;8(2):158-9 [14625700.001]
  • [Cites] Ann Surg. 2004 Oct;240(4):578-83; discussion 583-5 [15383785.001]
  • [Cites] Dis Colon Rectum. 1992 Sep;35(9):897-901 [1387358.001]
  • [Cites] J Urol. 2003 Jun;169(6):2242-3 [12771759.001]
  • [Cites] Surg Gynecol Obstet. 1984 Aug;159(2):162-3 [6463828.001]
  • [Cites] Dis Colon Rectum. 1997 Aug;40(8):954-7 [9269813.001]
  • [Cites] Br J Obstet Gynaecol. 1988 Apr;95(4):382-5 [3382611.001]
  • [Cites] Surg Gynecol Obstet. 1985 Apr;160(4):365-6 [3983803.001]
  • [Cites] Hernia. 2002 Sep;6(3):144-7 [12209305.001]
  • [Cites] Cancer. 1985 Sep 15;56(6):1300-4 [3928128.001]
  • [Cites] Surg Gynecol Obstet. 1983 Sep;157(3):269-71 [6612575.001]
  • [Cites] Surg Gynecol Obstet. 1979 Jul;149(1):33-5 [287202.001]
  • [Cites] Gastroenterol Clin Biol. 2002 Aug-Sep;26(8-9):686-95 [12434069.001]
  • [Cites] Dis Colon Rectum. 1989 Jul;32(7):628-30 [2661180.001]
  • [Cites] Dis Colon Rectum. 1992 Dec;35(12):1157-60 [1473418.001]
  • [Cites] Hepatogastroenterology. 2002 Jul-Aug;49(46):1023-6 [12143192.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1984 Jan;10(1):55-62 [6698825.001]
  • [Cites] Am Surg. 1994 Jul;60(7):473-82; discussion 482-3 [8010560.001]
  • [Cites] Cancer. 1991 Dec 15;68(12):2545-9 [1657360.001]
  • [Cites] Arch Surg. 1991 Mar;126(3):366-9 [1847798.001]
  • [Cites] Dis Colon Rectum. 1995 Mar;38(3):276-80 [7882792.001]
  • [Cites] Oncology (Williston Park). 1998 Jan;12(1):51-4; discussion 54, 60, 62, passim [9474587.001]
  • [Cites] Surg Gynecol Obstet. 1989 Jun;168(6):475-80 [2727876.001]
  • [Cites] Aust N Z J Surg. 1989 Nov;59(11):895-7 [2818352.001]
  • [Cites] Am J Obstet Gynecol. 2001 Jul;185(1):32-40 [11483900.001]
  • [Cites] J Am Coll Surg. 1999 Dec;189(6):611-24 [10589598.001]
  • [Cites] Surg Gynecol Obstet. 1979 Aug;149(2):206-8 [462352.001]
  • [Cites] Curr Opin Obstet Gynecol. 2002 Oct;14(5):527-35 [12401983.001]
  • [Cites] Clinics (Sao Paulo). 2005 Feb;60(1):71-4 [15838584.001]
  • [Cites] N Engl J Med. 1994 Aug 25;331(8):502-7 [8041415.001]
  • [Cites] Dis Colon Rectum. 1987 Jan;30(1):21-4 [3803102.001]
  • [Cites] Obstet Gynecol. 2000 Jun;95(6 Pt 2):1029 [10808017.001]
  • [Cites] Dis Colon Rectum. 1988 Jan;31(1):17-21 [2835216.001]
  • [Cites] N Engl J Med. 1986 Nov 13;315 (20):1294-5 [3773947.001]
  • [Cites] Urology. 2001 Sep;58(3):482-6 [11549510.001]
  • [Cites] Dis Colon Rectum. 1997 Nov;40(11):1336-41 [9369109.001]
  • [Cites] Eur J Surg. 2001 Sep;167(9):713-4 [11759745.001]
  • (PMID = 17024307.001).
  • [ISSN] 1265-4906
  • [Journal-full-title] Hernia : the journal of hernias and abdominal wall surgery
  • [ISO-abbreviation] Hernia
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


5. Lauretti S, Mosca A, D'Alfonso V, Donadio D, Brisciani A: Primitive mucinous adenocarcinoma of the bladder. A case report. Arch Ital Urol Androl; 2006 Mar;78(1):32-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primitive mucinous adenocarcinoma of the bladder. A case report.
  • Primary mucing-producing adenocarcinoma of the bladder is a rare, highly malignant tumor.
  • It is classified as the third most frequent histologic type of bladder carcinoma characterized by a poor response to radiotherapy and/or chemotherapy.
  • Only surgery seems to offer the best approach to this unusual cancer The authors report the pathological findings and the clinical course of a 45-years old man with a primary mucin-secreting adenocarcinoma of the bladder.

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16752888.001).
  • [ISSN] 1124-3562
  • [Journal-full-title] Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
  • [ISO-abbreviation] Arch Ital Urol Androl
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


6. Ibele AR, Koplin SA, Slaughenhoupt BL, Kryger JV, Friedl A, Lund DP: Colonic adenocarcinoma in a 13-year-old with cystic fibrosis. J Pediatr Surg; 2007 Oct;42(10):E1-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colonic adenocarcinoma in a 13-year-old with cystic fibrosis.
  • Here we report a case of colonic adenocarcinoma presenting as pneumaturia in a 13-year-old patient with cystic fibrosis.
  • [MeSH-major] Adenocarcinoma / complications. Cecal Neoplasms / complications. Cystic Fibrosis / complications
  • [MeSH-minor] Adolescent. Air. Anastomosis, Surgical. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Colectomy. Combined Modality Therapy. Fluorouracil / administration & dosage. Humans. Intestinal Fistula / etiology. Intestinal Fistula / surgery. Intestinal Fistula / urine. Leucovorin / administration & dosage. Male. Organoplatinum Compounds / administration & dosage. Urinary Bladder Fistula / etiology. Urinary Bladder Fistula / surgery. Urinary Bladder Fistula / urine. Urine

  • Genetic Alliance. consumer health - BabysFirstTest - Cystic Fibrosis.
  • Genetic Alliance. consumer health - Cystic Fibrosis.
  • MedlinePlus Health Information. consumer health - Cystic Fibrosis.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17923181.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil
  •  go-up   go-down


7. Morii A, Furuya Y, Fujiuchi Y, Akashi T, Ishizawa S, Fuse H: Urachal signet ring cell carcinoma. Int J Urol; 2007 Apr;14(4):360-1
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Urachal adenocarcinoma is a rare neoplasm associated with poor prognosis.
  • [MeSH-major] Carcinoma, Signet Ring Cell / pathology. Urachus. Urinary Bladder Neoplasms / pathology

  • Genetic Alliance. consumer health - Signet ring cell carcinoma.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17470172.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


8. Narayan K, van Dyk S, Bernshaw D, Rajasooriyar C, Kondalsamy-Chennakesavan S: Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival. Int J Radiat Oncol Biol Phys; 2009 Aug 1;74(5):1529-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival.
  • PURPOSE: To compare patterns of failure, late toxicities, and survival in locally advanced cervical cancer patients treated by either low-dose-rate (LDR) or conformal high-dose-rate (HDRc) brachytherapy as a part of curative radiotherapy.
  • MATERIALS AND METHODS: A retrospective comparative study of 217 advanced cervix cancer patients was conducted; 90 of these patients received LDR and 127 received HDRc brachytherapy.
  • Sixty-eight percent (87/127) of patients treated by HDRc remained asymptomatic, whereas 42% (38/90) of patients were asymptomatic from the bowel and bladder symptoms after treatment with LDR.
  • [MeSH-minor] Adenocarcinoma / drug therapy. Adenocarcinoma / mortality. Adenocarcinoma / pathology. Adenocarcinoma / radiotherapy. Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / drug therapy. Carcinoma, Squamous Cell / mortality. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / radiotherapy. Combined Modality Therapy / methods. Female. Humans. Middle Aged. Radiotherapy Dosage. Radiotherapy, Conformal / adverse effects. Radiotherapy, Conformal / methods. Radiotherapy, Conformal / mortality. Retrospective Studies. Treatment Failure. Young Adult


9. Shigehara K, Taya T, Hisazumi H: Primary adenocarcinoma in the bladder diverticulum. Scand J Urol Nephrol; 2008;42(5):481-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary adenocarcinoma in the bladder diverticulum.
  • Cystoscopy revealed a papillary tumor within the diverticulum of the bladder.
  • A transurethral resection was performed and histopathological examination revealed adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / pathology. Diverticulum / pathology. Urinary Bladder Diseases / pathology. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Aged. Biopsy. Cystectomy. Cystoscopy. Diagnosis, Differential. Hematuria / etiology. Humans. Male. Tomography, X-Ray Computed. Urinary Bladder / pathology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18792856.001).
  • [ISSN] 0036-5599
  • [Journal-full-title] Scandinavian journal of urology and nephrology
  • [ISO-abbreviation] Scand. J. Urol. Nephrol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Sweden
  •  go-up   go-down


10. Manunta A, Vincendeau S, Kiriakou G, Lobel B, Guillé F: Non-transitional cell bladder carcinomas. BJU Int; 2005 Mar;95(4):497-502
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Non-transitional cell bladder carcinomas.
  • [MeSH-major] Adenocarcinoma. Carcinoma, Squamous Cell. Urinary Bladder Neoplasms

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15705067.001).
  • [ISSN] 1464-4096
  • [Journal-full-title] BJU international
  • [ISO-abbreviation] BJU Int.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 8N3DW7272P / Cyclophosphamide
  • [Number-of-references] 50
  •  go-up   go-down


11. Hansel DE, Nadasdy T, Epstein JI: Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma. Am J Surg Pathol; 2007 Aug;31(8):1231-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma.
  • All 8 patients were elderly men who had a prior or concurrent history of acinar prostate cancer (n=4), combined acinar prostate and urothelial carcinoma (n=1), urothelial-type adenocarcinoma of the prostate (n=1), bladder urothelial carcinoma (n=1), or no prior reported prostatic or urothelial abnormalities (n=1).
  • Awareness of this entity and the use of ancillary techniques can aid in the diagnosis of this unusual form of nephrogenic adenoma.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Adenoma / pathology. Fibroma / pathology. Urologic Neoplasms / pathology
  • [MeSH-minor] Aged. Biomarkers, Tumor / analysis. Diagnosis, Differential. Humans. Male. Middle Aged. Mucins / analysis. Neoplasms, Multiple Primary. Urothelium / chemistry. Urothelium / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17667548.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Mucins
  •  go-up   go-down


12. Ramirez PT, Slomovitz BM, Soliman PT, Coleman RL, Levenback C: Total laparoscopic radical hysterectomy and lymphadenectomy: the M. D. Anderson Cancer Center experience. Gynecol Oncol; 2006 Aug;102(2):252-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Total laparoscopic radical hysterectomy and lymphadenectomy: the M. D. Anderson Cancer Center experience.
  • Data collected included age, body mass index, stage, histopathologic subtype, tumor grade, estimated blood loss, perioperative blood transfusions, number and status of lymph nodes obtained, status of surgical margins, length of hospital stay, time to resumption of normal bladder function, intraoperative and postoperative complications, and disease-free interval.
  • Eighteen patients had cervix cancer (5 stage IA2 and 13 stage IB1), and 2 had endometrial cancer (1 stage IB and 1 stage IIIA).
  • Among those with cervix cancer, 12 had adenocarcinoma, 4 squamous cell carcinoma, and 2 adenosquamous carcinoma.
  • The median time to resumption of normal bladder function was 16 days (range, 13-29).
  • [MeSH-minor] Adenocarcinoma / surgery. Adult. Aged. Carcinoma, Adenosquamous / surgery. Carcinoma, Squamous Cell / surgery. Female. Humans. Middle Aged

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • MedlinePlus Health Information. consumer health - Hysterectomy.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Gynecol Oncol. 2007 Feb;104(2):501; author reply 501-3 [17157902.001]
  • (PMID = 16472844.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Mavrich Villavicencio H, Esquena S, Palou Redorta J, Gómez Ruíz JJ: [Robotic radical prostatectomy: overview of our learning curve]. Actas Urol Esp; 2007 Jun;31(6):587-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Prostatectomía radical robótica: revisión de nuestra curva de aprendizaje.
  • OBJECTIVE: We present the first cases of our robotic radical prostatectomy with Da Vinci (RRPdaV) that corresponds to the learning curve (LC) of the surgeon that has initiated with this technique.
  • We analyzed: Surgical time, blood loss, conversion rate, intra and postoperative complications, hospital stay and days of bladder catheterization.
  • [MeSH-major] Adenocarcinoma / surgery. Laparoscopy / methods. Prostatectomy / methods. Prostatic Neoplasms / surgery. Robotics / instrumentation
  • [MeSH-minor] Aged. Blood Loss, Surgical. Erectile Dysfunction / epidemiology. Erectile Dysfunction / etiology. Humans. Learning. Length of Stay / statistics & numerical data. Male. Middle Aged. Minimally Invasive Surgical Procedures. Postoperative Complications / epidemiology. Retrospective Studies. Time Factors. Treatment Outcome. Urinary Incontinence / epidemiology. Urinary Incontinence / etiology

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17896554.001).
  • [ISSN] 0210-4806
  • [Journal-full-title] Actas urologicas españolas
  • [ISO-abbreviation] Actas Urol Esp
  • [Language] spa
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 17
  •  go-up   go-down


14. Mannai S, Kraïem T, Gharbi L, Haoues N, Mestiri H, Khalfallah MT: [Congenital cystic dilatation of bile ducts]. Ann Chir; 2006 Jul-Aug;131(6-7):369-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Anatomopathologic examination showed an adenocarcinoma of a common bile duct cyst.
  • In one case, a cancer of the gall bladder associated to a common bile duct cyst in another case.
  • [MeSH-minor] Acute Disease. Adolescent. Adult. Aged. Aged, 80 and over. Anastomosis, Surgical. Bile Ducts, Intrahepatic / abnormalities. Caroli Disease / diagnosis. Caroli Disease / surgery. Child. Child, Preschool. Cholangitis / etiology. Cholecystitis / complications. Dilatation. Dilatation, Pathologic / congenital. Drainage. Female. Hepatectomy. Humans. Jejunum / surgery. Liver / surgery. Male. Middle Aged. Postoperative Complications. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Bile Duct Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16630531.001).
  • [ISSN] 0003-3944
  • [Journal-full-title] Annales de chirurgie
  • [ISO-abbreviation] Ann Chir
  • [Language] fre
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


15. Raz O, Stav K, Mendlovic S, Bar I, Zisman A: Exceptional site of metastatic adenocarcinoma of the lung. Isr Med Assoc J; 2007 Feb;9(2):119-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Exceptional site of metastatic adenocarcinoma of the lung.
  • [MeSH-major] Adenocarcinoma / pathology. Lung Neoplasms / pathology. Urinary Bladder / pathology. Urinary Bladder Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17348487.001).
  • [ISSN] 1565-1088
  • [Journal-full-title] The Israel Medical Association journal : IMAJ
  • [ISO-abbreviation] Isr. Med. Assoc. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Israel
  •  go-up   go-down


16. Zwahlen D, Jezioranski J, Chan P, Haider MA, Cho YB, Yeung I, Levin W, Manchul L, Fyles A, Milosevic M: Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix. Int J Radiat Oncol Biol Phys; 2009 Jul 15;74(4):1157-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix.
  • PURPOSE: To determine the feasibility and benefits of optimized magnetic resonance imaging (MRI)-guided brachytherapy (BT) for cancer of the cervix.
  • METHODS AND MATERIALS: A total of 20 patients with International Federation of Gynecology and Obstetrics Stage IB-IV cervical cancer had an MRI-compatible intrauterine BT applicator inserted after external beam radiotherapy.
  • MRI scans were acquired, and the gross tumor volume at diagnosis and at BT, the high-risk (HR) and intermediate-risk clinical target volume (CTV), and rectal, sigmoid, and bladder walls were delineated.
  • The minimal dose to the contiguous 2 cm(3) of the rectal, sigmoid, and bladder wall volume was 16 +/- 6.2, 25 +/- 8.7, and 31 +/- 9.2 Gy, respectively.
  • In these patients, the HR percentage of volume treated to >or=100% of the intended dose approached 100% in all cases, and the minimal dose to the contiguous 2-cm(3) of the rectum, sigmoid, and bladder was 12-32% less than with conventional BT planning.
  • CONCLUSION: MRI-based BT for cervical cancer has the potential to optimize primary tumor dosimetry and reduce the dose to critical normal tissues, particularly in patients with small tumors.
  • [MeSH-minor] Adenocarcinoma, Clear Cell / pathology. Adenocarcinoma, Clear Cell / radiotherapy. Adult. Aged. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / radiotherapy. Colon, Sigmoid / anatomy & histology. Feasibility Studies. Female. Humans. Middle Aged. Radiation Injuries / prevention & control. Radiotherapy Dosage. Rectum / anatomy & histology. Tumor Burden. Urinary Bladder / anatomy & histology


17. Zangrilli A, Saraceno R, Sarmati L, Orlandi A, Bianchi L, Chimenti S: Erysipeloid cutaneous metastasis from bladder carcinoma. Eur J Dermatol; 2007 Nov-Dec;17(6):534-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Erysipeloid cutaneous metastasis from bladder carcinoma.
  • Cutaneous metastases from bladder cancer are uncommon, especially in the female population.
  • We describe a 56-year-old female with a history of bladder adenocarcinoma (T3N0M0) who presented erythematous plaques with an erysipelas-like appearance located on the groins and thighs.
  • Histopathology and immunohistochemistry from skin lesions were consistent with metastases from bladder carcinoma.
  • [MeSH-major] Adenocarcinoma / secondary. Skin Neoplasms / secondary. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Erysipelas / diagnosis. Female. Humans. Immunohistochemistry. Middle Aged

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17951136.001).
  • [ISSN] 1167-1122
  • [Journal-full-title] European journal of dermatology : EJD
  • [ISO-abbreviation] Eur J Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


18. Pagano S, Ruggeri P, Rovellini P, Bottanelli A: The anterior ileal conduit: results of 100 consecutive cases. J Urol; 2005 Sep;174(3):959-62; discussion 962
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: The ileal conduit of Bricker is still widely used for urinary diversion after radical cystectomy for bladder carcinoma.
  • RESULTS: A total of 100 consecutive patients after radical cystectomy for bladder cancer had anterior ileal conduit.
  • The surgical revision and the treatment of ureteroileal stenoses with anterograde percutaneous ureteral stenting were not complicated procedures.
  • [MeSH-major] Adenocarcinoma / surgery. Carcinoma, Squamous Cell / surgery. Carcinoma, Transitional Cell / surgery. Cystectomy. Postoperative Complications / etiology. Urinary Bladder Neoplasms / surgery. Urinary Diversion / methods

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16094008.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Anjaneyulu V, Shankar-Swarnalatha G, Rao SC: Carcinoid tumor of the gall bladder. Ann Diagn Pathol; 2007 Apr;11(2):113-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Carcinoid tumor of the gall bladder.
  • Carcinoid of the gall bladder and bile duct is a rare tumor.
  • Primary gall bladder and biliary duct system carcinoids constitute less than 1% of all carcinoid tumors arising from different parts of the body.
  • We describe a case of carcinoid tumor of the gall bladder in a 53-year-old woman.
  • [MeSH-minor] Adenocarcinoma / diagnosis. Biomarkers, Tumor / analysis. Diagnosis, Differential. Female. Humans. Immunoenzyme Techniques. Middle Aged. Silver Nitrate. Silver Staining. Tomography, X-Ray Computed. Treatment Outcome

  • Genetic Alliance. consumer health - Carcinoid Tumor.
  • MedlinePlus Health Information. consumer health - Carcinoid Tumors.
  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • Hazardous Substances Data Bank. SILVER NITRATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17349570.001).
  • [ISSN] 1092-9134
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Grimelius stain; 95IT3W8JZE / Silver Nitrate
  •  go-up   go-down


20. Ito H, Hagiwara M, Furuuchi T, Kanai K, Kodaira K, Ninomiya A, Nakamura S: [A case of double cancer involving the urachus and the bladder]. Hinyokika Kiyo; 2010 Jan;56(1):41-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of double cancer involving the urachus and the bladder].
  • We performed cystoscopy, and found a solid tumor at the dome of the bladder.
  • Transurethral resection of bladder tumor was performed.
  • A solid tumor at the dome and two papillary tumors at the right lateral region of the bladder were observed.
  • A pathological examination revealed adenocarcinoma from the solid tumor and urothelial carcinoma from the papillary tumors.
  • Under a diagnosis of double cancer, adenocarcinoma of the urachus and urothelial carcinoma of bladder, we performed a total cystectomy, neobladder and total resection of the urachus.
  • [MeSH-major] Adenocarcinoma / pathology. Neoplasms, Multiple Primary / pathology. Urachus. Urinary Bladder Neoplasms / pathology

  • Genetic Alliance. consumer health - Bladder cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20104009.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


21. Obando JA, Samii JM, Yasrebi M: A case of two synchronous primary lung tumors demonstrated by FDG positron emission tomography. Clin Nucl Med; 2008 Nov;33(11):775-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / radionuclide imaging. Carcinoma, Squamous Cell / radionuclide imaging. Fluorodeoxyglucose F18 / pharmacokinetics. Lung Neoplasms / radionuclide imaging. Neoplasms, Multiple Primary / radionuclide imaging
  • [MeSH-minor] Aged, 80 and over. Diagnosis, Differential. Humans. Male. Positron-Emission Tomography / methods. Prostatic Neoplasms / pathology. Radiopharmaceuticals / pharmacokinetics. Urinary Bladder Neoplasms / pathology. Whole Body Imaging

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18936611.001).
  • [ISSN] 1536-0229
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


22. Funahashi Y, Kamihira O, Kasugai S, Kimura K, Fukatsu A, Matsuura O: [Triple cancer in the urinary system: a case report]. Hinyokika Kiyo; 2007 Nov;53(11):813-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Triple cancer in the urinary system: a case report].
  • Cystoscopy showed many papillary bladder tumors under 5 mm in size.
  • Our case should be called triple cancer because bladder cancer was thought to be daughter tumor of renal pelvic tumor.
  • This is, to our knowledge, the 11th case report that occurred in the urinary tact, and the first case that needed total resection of urinary tract.
  • [MeSH-major] Adenocarcinoma / diagnosis. Carcinoma, Renal Cell / diagnosis. Kidney Neoplasms / diagnosis. Kidney Pelvis. Neoplasms, Multiple Primary. Prostatic Neoplasms / diagnosis. Urinary Bladder Neoplasms / diagnosis


23. Singh A, Kinoshita Y, Rovito PM Jr, Landas S, Silberstein J, Nsouli I, Wang CY, Haas GP: Higher than expected association of clinical prostate and bladder cancers. J Urol; 2005 May;173(5):1526-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Higher than expected association of clinical prostate and bladder cancers.
  • PURPOSE: In this study we evaluated the risk of a second malignancy of the bladder or prostate in patients with a previous diagnosis of prostate cancer (PCa) or urothelial cancer (TCC).
  • All patients with TCC presented with hematuria or irritative voiding symptoms and the diagnoses were confirmed with a tissue diagnosis.
  • Average age at PCa and TCC diagnosis +/- SD was 68.2 +/- 7.9 and 68.2 +/- 10.4 years, respectively.
  • SIR for lung, renal or colon cancer was not significantly different from what was expected.
  • CONCLUSIONS: Patients with PCa have higher incidence of bladder cancer and those with bladder cancer have a higher incidence of PCa.
  • [MeSH-major] Adenocarcinoma / epidemiology. Carcinoma, Transitional Cell / epidemiology. Neoplasms, Second Primary / epidemiology. Prostatic Neoplasms / epidemiology. Urinary Bladder Neoplasms / epidemiology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ReprintIn] J Urol. 2008 May;179(5 Suppl):S2-5 [18405742.001]
  • (PMID = 15821472.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


24. Terada T: Adenosquamous Carcinoma of the Stomach: Report of Two Cases. Gastroenterology Res; 2009 Feb;2(1):54-56
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathologically, the gastric tumor consisted of a mixture of adenocarcinoma (30% in area) and squamous cell carcinoma (70% in areas).
  • The adenocarcinoma consisted of signet ring cell carcinoma, poorly differentiated carcinoma, and tubular adenocarcinoma.
  • The gall bladder, lymph nodes and peritoneum showed metastases of adenocarcinoma.
  • Pathologically the gastric tumor was composed of a mixture of adenocarcinoma (10%) and squamous cell carcinoma (90%).
  • The adenocarcinoma element consisted of signet ring cell carcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27956953.001).
  • [ISSN] 1918-2805
  • [Journal-full-title] Gastroenterology research
  • [ISO-abbreviation] Gastroenterology Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Keywords] NOTNLM ; Adenosquamous carcinoma / Histopathology / Stomach
  •  go-up   go-down


25. Weidle UH, Evtimova V, Alberti S, Guerra E, Fersis N, Kaul S: Cell growth stimulation by CRASH, an asparaginase-like protein overexpressed in human tumors and metastatic breast cancers. Anticancer Res; 2009 Apr;29(4):951-63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • On the other hand, 36/50 ovarian carcinomas, 16/78 mammary carcinomas, 6/6 uroepithelial bladder carcinomas and 5/33 colon carcinomas scored positive for CRASH, with the absence of reactivity in the corresponding normal tissues.
  • The somatic knock-out of CRASH resulted in significant inhibition of growth of KM12L4A colon carcinoma cells, which abundantly express CRASH, whereas the proliferation of the syngeneic, weakly-expressing, slowly-growing KL12SM was not affected.
  • [MeSH-minor] Adenocarcinoma / metabolism. Adenocarcinoma / secondary. Amino Acid Sequence. Animals. Antibodies, Monoclonal / immunology. Blotting, Western. Carcinoma, Transitional Cell / metabolism. Carcinoma, Transitional Cell / secondary. Cell Line, Tumor. Cystadenocarcinoma / metabolism. Cystadenocarcinoma / secondary. Female. Humans. Immunoenzyme Techniques. Mice. Mice, Inbred BALB C. Molecular Sequence Data. Prognosis. RNA, Small Interfering / pharmacology. Sequence Homology, Amino Acid

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19414332.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Autoantigens; 0 / RNA, Small Interfering; EC 3.5.1.- / ASRGL1 protein, human; EC 3.5.1.1 / Asparaginase
  •  go-up   go-down


26. Vardar E: Histologic variants of infiltrating urothelial carcinoma. Arch Pathol Lab Med; 2008 Oct;132(10):1546-7author reply 1547
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / metabolism. Adenocarcinoma / secondary. Homeodomain Proteins / metabolism. Urinary Bladder Neoplasms / metabolism. Urinary Bladder Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Arch Pathol Lab Med. 2007 Aug;131(8):1244-56 [17683187.001]
  • (PMID = 18834203.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CDX2 protein, human; 0 / Homeodomain Proteins; 0 / Keratin-20; 0 / Keratin-7; 0 / Microfilament Proteins; 0 / Thrombomodulin; 0 / villin
  •  go-up   go-down


27. Sanli O, Acar O, Celtik M, Oktar T, Kilicaraslan I, Ozcan F, Tunc M, Esen T: Should prostate cancer status be determined in patients undergoing radical cystoprostatectomy? Urol Int; 2006;77(4):307-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Should prostate cancer status be determined in patients undergoing radical cystoprostatectomy?
  • INTRODUCTION: We estimate the frequency of prostate cancers detected incidentally in radical cystoprostatectomy specimens and discuss whether the prostate cancer status should be determined in patients undergoing radical cystoprostatectomy.
  • MATERIALS AND METHODS: A total of 97 radical cystoprostatectomies without evidence of prostate cancer on digital rectal examination were performed for transitional cell carcinomas of the bladder between January 2001 and May 2004.
  • RESULTS: The overall incidence of prostate cancer detected in radical cystoprostatectomy specimens was 21.6% (21/97 specimens).
  • CONCLUSIONS: Despite the high prevalence of incidental prostate carcinomas among patients with bladder cancer undergoing cystoprostatectomy, the vast majority of the cancers are organ confined.
  • However, the prostate cancer status should be determined on the basis of digital rectal examination and prostate-specific antigen in patients undergoing radical cystoprostatectomy - especially if prostate-sparing cystectomy is planned.
  • [MeSH-major] Adenocarcinoma / pathology. Cystectomy. Prostatectomy. Prostatic Neoplasms / pathology
  • [MeSH-minor] Aged. Carcinoma, Transitional Cell / pathology. Carcinoma, Transitional Cell / surgery. Diagnosis, Differential. Follow-Up Studies. Humans. Incidence. Intraoperative Period. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Retrospective Studies. Urinary Bladder Neoplasms / pathology. Urinary Bladder Neoplasms / surgery

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17135779.001).
  • [ISSN] 0042-1138
  • [Journal-full-title] Urologia internationalis
  • [ISO-abbreviation] Urol. Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


28. Peterson RM, Ollayos C, Merchant D: Urachal adenocarcinoma: incidental finding at the time of surgery for ruptured appendicitis. JSLS; 2006 Jul-Sep;10(3):392-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Urachal adenocarcinoma: incidental finding at the time of surgery for ruptured appendicitis.
  • BACKGROUND: The urachus is a vestigial structure between the dome of the bladder and the umbilicus.
  • Urachal adenocarcinoma is an exceedingly rare type of tumor.
  • RESULTS: Pathology confirmed the diagnosis of perforated appendicitis and a mucinous-producing urachal adenocarcinoma.
  • A standard right lower quadrant incision for an open technique would likely have resulted in omission of this lesion, and the patient would have presented at a more typical late stage of her cancer development with significantly more morbidity.

  • Genetic Alliance. consumer health - Urachal adenocarcinoma.
  • MedlinePlus Health Information. consumer health - Appendicitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Urol. 2003 Apr;169(4):1295-8 [12629346.001]
  • [Cites] Int J Gynecol Pathol. 2003 Apr;22(2):189-93 [12649676.001]
  • [Cites] J Clin Pathol. 2003 Nov;56(11):882 [14600142.001]
  • [Cites] Br J Urol. 1971 Feb;43(1):4-15 [4926456.001]
  • [Cites] Surgery. 1975 May;77(5):726-9 [47654.001]
  • [Cites] J Urol. 1977 Jan;117(1):54-6 [830970.001]
  • [Cites] Cancer. 1991 Apr 15;67(8):2165-72 [1706216.001]
  • [Cites] Urology. 1985 Sep;26(3):218-21 [4035835.001]
  • [Cites] Urology. 1993 Dec;42(6):635-9 [8256396.001]
  • [Cites] J Urol. 1994 Feb;151(2):365-6 [8283526.001]
  • [Cites] Cancer. 1954 Jan;7(1):119-35 [13126906.001]
  • [Cites] Cancer. 1955 Jul-Aug;8(4):741-58 [13240656.001]
  • [Cites] J Urol. 1978 Dec;120(6):764-6 [215792.001]
  • (PMID = 17212903.001).
  • [ISSN] 1086-8089
  • [Journal-full-title] JSLS : Journal of the Society of Laparoendoscopic Surgeons
  • [ISO-abbreviation] JSLS
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3015710
  •  go-up   go-down


29. Vauhkonen H, Böhling T, Eissa S, Shoman S, Knuutila S: Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis? Cancer Genet Cytogenet; 2007 Sep;177(2):153-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?
  • Bladder cancer is the most common malignancy in many tropical and subtropical areas, correlating well with the endemicity of schistostomiasis.
  • The majority of schistostomiasis-associated (SA) bladder cancers are squamous cell cancers, whereas the majority of non-SA cases in the Western world are transitional cell cancers, suggesting different carcinogenetic mechanisms.
  • Comparison of the DNA copy number profiles to previously reported profiles of SA transitional cell carcinoma and squamous cell carcinoma revealed similarities (e.g., gains at 5p and 8q), as well as differences (e.g., TCC- and SCC-associated losses at 18p and 20p, and adenocarcinoma-associated gains at 20q).
  • [MeSH-major] Carcinoma, Squamous Cell / genetics. Carcinoma, Transitional Cell / genetics. Gene Expression Profiling. Nucleic Acid Hybridization. Schistosomiasis / complications. Urinary Bladder Neoplasms / genetics

  • Genetic Alliance. consumer health - Schistosomiasis.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Cancer Genet Cytogenet. 2008 Jan 15;180(2):160-2 [18206545.001]
  • (PMID = 17854674.001).
  • [ISSN] 0165-4608
  • [Journal-full-title] Cancer genetics and cytogenetics
  • [ISO-abbreviation] Cancer Genet. Cytogenet.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm
  •  go-up   go-down


30. Lee W: Urachal adenocarcinoma metastatic to the ovaries resembling primary ovarian mucinous carcinoma: a case report with the immunohistochemical study. Int J Clin Exp Pathol; 2010;4(1):118-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Urachal adenocarcinoma metastatic to the ovaries resembling primary ovarian mucinous carcinoma: a case report with the immunohistochemical study.
  • I report here on a case of urachal adenocarcinoma that metastasized to bilateral ovaries in a 72-year-old female.
  • The kidney CT revealed a solid mass with calcification in the bladder dome, which suggested urachal carcinoma.
  • Histologically, the tumor corresponded to mucinous adenocarcinoma and centered at the bladder wall with predominant invasion of the muscularis.
  • [MeSH-major] Adenocarcinoma / secondary. Ovarian Neoplasms / secondary
  • [MeSH-minor] Aged. Biomarkers, Tumor / metabolism. Carcinoma, Squamous Cell / metabolism. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / surgery. Female. Humans. Immunohistochemistry. Kidney Neoplasms / radiography. Kidney Neoplasms / secondary. Palliative Care. Tomography, X-Ray Computed. Urinary Bladder Neoplasms / metabolism. Urinary Bladder Neoplasms / pathology. Urinary Bladder Neoplasms / surgery

  • Genetic Alliance. consumer health - Urachal adenocarcinoma.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 2009 May;33(5):659-68 [19252435.001]
  • [Cites] J Urol. 2008 Aug;180(2):720 [18554640.001]
  • [Cites] Urology. 2001 Sep;58(3):462 [11549502.001]
  • [Cites] Am J Surg Pathol. 2003 Mar;27(3):281-92 [12604884.001]
  • [Cites] AJR Am J Roentgenol. 2003 Apr;180(4):1183-4 [12646487.001]
  • [Cites] Int J Gynecol Pathol. 2003 Apr;22(2):189-93 [12649676.001]
  • [Cites] J Urol. 1984 Jan;131(1):1-8 [6361280.001]
  • [Cites] Virchows Arch. 1995;426(5):529-32 [7633664.001]
  • [Cites] J Urol. 1997 Nov;158(5):1722-7 [9334587.001]
  • [Cites] Int J Gynecol Pathol. 2005 Jan;24(1):4-25 [15626914.001]
  • [Cites] Am J Surg Pathol. 2006 Sep;30(9):1130-9 [16931958.001]
  • [Cites] Mod Pathol. 2006 Nov;19(11):1421-8 [16980943.001]
  • [Cites] Cancer. 2007 Dec 1;110(11):2434-40 [17932892.001]
  • [Cites] Am J Surg Pathol. 2007 Dec;31(12):1788-99 [18043033.001]
  • [Cites] Int J Gynecol Pathol. 2008 Jul;27(3):366-79 [18580314.001]
  • [Cites] Int J Gynecol Cancer. 2009 Dec;19(9):1539-41 [19955933.001]
  • (PMID = 21228934.001).
  • [ISSN] 1936-2625
  • [Journal-full-title] International journal of clinical and experimental pathology
  • [ISO-abbreviation] Int J Clin Exp Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; Urachal cancer
  • [Other-IDs] NLM/ PMC3016110
  • [Keywords] NOTNLM ; Urachus / adenocarcinoma / metastasis / mucinous / ovarian neoplasm
  •  go-up   go-down


31. Molavi D, Argani P: Distinguishing benign dissecting mucin (stromal mucin pools) from invasive mucinous carcinoma. Adv Anat Pathol; 2008 Jan;15(1):1-17
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This article reviews diagnostic criteria for the differential diagnosis of mucinous lesions of the breast, pancreas, biliary tract, colon, appendix, and bladder, emphasizing practical points, which we find helpful in daily diagnostic surgical pathology practice.
  • [MeSH-major] Adenocarcinoma, Mucinous / diagnosis. Adenocarcinoma, Mucinous / pathology. Epithelial Cells / pathology. Mucins
  • [MeSH-minor] Breast Neoplasms / diagnosis. Breast Neoplasms / pathology. Colonic Neoplasms / diagnosis. Colonic Neoplasms / pathology. Diagnosis, Differential. Female. Humans. Male. Pancreatic Neoplasms / diagnosis. Pancreatic Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18156808.001).
  • [ISSN] 1072-4109
  • [Journal-full-title] Advances in anatomic pathology
  • [ISO-abbreviation] Adv Anat Pathol
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA 88843
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Mucins
  • [Number-of-references] 51
  •  go-up   go-down


32. Jain V, Gupta K, Kudva R, Rodrigues GS: A case of ovarian metastasis of gall bladder carcinoma simulating primary ovarian neoplasm: diagnostic pitfalls and review of literature. Int J Gynecol Cancer; 2006 Jan-Feb;16 Suppl 1:319-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of ovarian metastasis of gall bladder carcinoma simulating primary ovarian neoplasm: diagnostic pitfalls and review of literature.
  • The best-known tumor of this type is signet ring cell adenocarcinoma (Krukenberg tumor) of gastric origin and large bowel.
  • The gall bladder and bile ducts are extremely rare sources of these metastases.
  • While clinical and imaging results suggested a primary ovarian carcinoma with incidental cholelithiasis and choledocholithiasis, the final diagnosis was obtained on the basis of histopathologic findings of resected specimen.
  • [MeSH-major] Adenocarcinoma / diagnosis. Gallbladder Neoplasms / diagnosis. Ovarian Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16515613.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil
  • [Number-of-references] 17
  •  go-up   go-down


33. Chaleoykitti B: Preoperative diagnosis of urinary bladder involvement in adenocarcinoma of colon and rectum. J Med Assoc Thai; 2005 Dec;88(12):1816-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative diagnosis of urinary bladder involvement in adenocarcinoma of colon and rectum.
  • OBJECTIVE: Objective of the study was to compare urinary symptoms, urinalysis, computed tomography, intravenous pyelography, ultrasonography between colorectal adenocarcinoma with urinary bladder involvement and without urinary bladder involvement.
  • MATERIAL AND METHOD: Patients with adenocarcinoma of the colon and rectum who had the first operation between January 1999 and October 2004 were included in the present study.
  • All patients were divided into the bladder adhesion group and nonadhesion group.
  • Sex, sites of tumor, urinary symptoms and preoperative investigations were compared.
  • 26 cases (5.7%) had bladder adhesion.
  • Males had more chance of having bladder involvement.
  • Sigmoid and rectum were the most common sites of bladder adhesion.
  • All cases with urinary symptoms had bladder involvement.
  • All cases whose computed tomography showed bladder involvement had bladder adhesion during surgery.
  • Ultrasonography and IVP did not help in detection of bladder invasion.
  • CONCLUSION: History of urinary symptoms, urinalysis, computed tomography should be routinely performed in patients with adenocarcinoma of the sigmoid and rectum to detect urinary bladder involvement and to inform modes of urinary tract diversion to patients before surgery.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / pathology. Colonic Neoplasms / pathology. Rectal Neoplasms / pathology. Urinary Bladder Neoplasms / diagnosis
  • [MeSH-minor] Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Invasiveness. Urinary Bladder / pathology. Urination Disorders / diagnosis. Urination Disorders / etiology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16518979.001).
  • [ISSN] 0125-2208
  • [Journal-full-title] Journal of the Medical Association of Thailand = Chotmaihet thangphaet
  • [ISO-abbreviation] J Med Assoc Thai
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Thailand
  •  go-up   go-down


34. Fan J, Ma LJ, Xia SJ, Yu L, Fu Q, Wu CQ, Huang XH, Jiang JM, Tang XD: Association between clinical characteristics and expression abundance of RTKN gene in human bladder carcinoma tissues from Chinese patients. J Cancer Res Clin Oncol; 2005 Mar;131(3):157-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association between clinical characteristics and expression abundance of RTKN gene in human bladder carcinoma tissues from Chinese patients.
  • PURPOSE: Bladder carcinoma is the most common urological malignancy in China.
  • Gene mutation may be one of causes of carcinogenesis in the cancer.
  • We therefore investigated the mRNA expression of RTKN gene in clinic malignant bladder carcinoma and explored the relationship between the novel gene and the cancer.
  • METHODS: Total RNA was extracted from 33 surgically resected specimens of bladder carcinoma and 19 specimens of tumor-free bladder tissues.
  • After the optimal reverse-transcription polymerase chain reaction condition was established, the mRNA expression levels of the RTKN gene in the lesions and tumor-free bladder tissues were examined semiquantitatively, and the relationships between expression levels of RTKN and clinical pathological features were analyzed.
  • RESULTS: The expression of RTKN gene mRNA in 33 human bladder carcinoma tissues was significantly higher than that in 19 human tumor-free bladder tissues (0.937+/-0.103 vs. 0.350+/-0.082).
  • The average ratio of RTKN expression in neoplasms to that in tumor-free bladder tissues was 0.350+/-0.164.
  • Although the chi(2) test demonstrated a statistically nonsignificant differences in RTKN expression between tumor stages Ta, T(1), and T(2) overall in the 33 human bladder carcinoma, the t test showed that there were statistically significant differences between solitary and multiple tumors, between the paired group aged younger or older than 70 years in 27 de novo bladder carcinoma patients, and between the groups with tumor larger or smaller than 2.25 cm(3).
  • CONCLUSIONS: These results suggest that the RTKN gene is involved in bladder carcinogenesis and progression in bladder carcinoma, indicating that RTKN gene could be a molecular target in cancer therapy.
  • [MeSH-major] Asian Continental Ancestry Group / genetics. Carcinoma, Transitional Cell / genetics. Carcinoma, Transitional Cell / pathology. Intracellular Signaling Peptides and Proteins / genetics. Urinary Bladder Neoplasms / genetics. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / genetics. Adenocarcinoma / pathology. Adult. Aged. Aged, 80 and over. Down-Regulation. Female. Gene Expression Regulation, Neoplastic. Humans. Male. Middle Aged. Reverse Transcriptase Polymerase Chain Reaction. Up-Regulation

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gene. 2001 Dec 27;281(1-2):103-13 [11750132.001]
  • [Cites] BJU Int. 2001 Feb;87(3):227-31 [11167647.001]
  • [Cites] Lab Invest. 2003 Jun;83(6):861-70 [12808121.001]
  • [Cites] Am J Pathol. 2002 Feb;160(2):579-84 [11839578.001]
  • [Cites] Br J Cancer. 2002 Sep 9;87(6):635-44 [12237774.001]
  • [Cites] Genes Dev. 1997 Sep 15;11(18):2295-322 [9308960.001]
  • [Cites] Nature. 1998 Jul 16;394(6690):295-9 [9685162.001]
  • [Cites] Gene. 2003 Jan 2;302(1-2):103-13 [12527201.001]
  • [Cites] Am J Physiol Cell Physiol. 2001 Aug;281(2):C571-8 [11443056.001]
  • [Cites] Br J Cancer. 1998;77(1):147-52 [9459160.001]
  • [Cites] Cancer Genet Cytogenet. 2000 Aug;121(1):73-7 [10958945.001]
  • [Cites] J Urol. 2002 Jul;168(1):61-6 [12050493.001]
  • [Cites] Clin Exp Metastasis. 2000;18(6):519-25 [11592309.001]
  • [Cites] J Biol Chem. 1996 Jun 7;271(23):13556-60 [8662891.001]
  • [Cites] EMBO J. 1994 Jun 1;13(11):2600-10 [7516876.001]
  • [Cites] J Biol Chem. 1998 Jul 24;273(30):18943-9 [9668072.001]
  • [Cites] Clin Cancer Res. 2003 Jul;9(7):2632-41 [12855641.001]
  • [Cites] FEBS Lett. 1997 Jun 23;410(1):68-72 [9247125.001]
  • [Cites] J Immunol. 1987 Nov 1;139(9):3132-8 [3312414.001]
  • [Cites] Genomics. 2000 Jun 15;66(3):328-32 [10873388.001]
  • [Cites] BJU Int. 2002 Mar;89(4):449-53 [11872041.001]
  • [Cites] Cancer Res. 2000 Nov 15;60(22):6519-25 [11103822.001]
  • [Cites] Circ Res. 1999 May 28;84(10):1186-93 [10347093.001]
  • (PMID = 15599595.001).
  • [ISSN] 0171-5216
  • [Journal-full-title] Journal of cancer research and clinical oncology
  • [ISO-abbreviation] J. Cancer Res. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Intracellular Signaling Peptides and Proteins; 0 / RTKN protein, human
  •  go-up   go-down


35. Adeniran AJ, Tamboli P: Clear cell adenocarcinoma of the urinary bladder: a short review. Arch Pathol Lab Med; 2009 Jun;133(6):987-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clear cell adenocarcinoma of the urinary bladder: a short review.
  • In this short review, we discuss clear cell adenocarcinoma of the urinary bladder, a rare tumor that primarily affects women.
  • Clear cell adenocarcinoma consists of cells with abundant clear cytoplasm, arranged in solid, glandular, or tubulocystic patterns.
  • [MeSH-major] Adenocarcinoma, Clear Cell. Urinary Bladder Neoplasms
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Prognosis

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19492895.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 25
  •  go-up   go-down


36. Xu T, Zhao WH, Wang XF, Huang XB, Xu QQ, Yang B, Ye XJ: [Analysis of pelvic lipomatosis and a case report of two brothers]. Beijing Da Xue Xue Bao; 2007 Aug 18;39(4):355-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A cystogram was performed and showed an elevated pear-shaped bladder secondary to thickening of the bladder wall.
  • Bladder and sigmoid were surrounded by homogeneous fat tissue.
  • Ileal bladder surgery was conducted.
  • Pelvic lipomatosis was a rare disorder of benign mature adipose tissue proliferation around the bladder and rectum, with urological or digestive system symptoms as the chief presentation.
  • Also there were risks of thrombosis, calculi and bladder adenocarcinoma.
  • The chief differential diagnosis was liposarcoma.
  • Currently, urinary diversion is the main treatment to relieve urinary obstruction.
  • [MeSH-major] Lipomatosis. Siblings. Urinary Bladder Diseases

  • Genetic Alliance. consumer health - Pelvic lipomatosis.
  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17657258.001).
  • [ISSN] 1671-167X
  • [Journal-full-title] Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
  • [ISO-abbreviation] Beijing Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] China
  • [Chemical-registry-number] Pelvic lipomatosis
  •  go-up   go-down


37. Gao ZL, Wu JT, Liu YJ, Shi L, Men CP, Zhang P, Liu QZ, Wang L: [Laparoscopic radical cystectomy for 43 patients with invasive bladder carcinoma]. Zhonghua Wai Ke Za Zhi; 2008 Apr 15;46(8):595-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Laparoscopic radical cystectomy for 43 patients with invasive bladder carcinoma].
  • OBJECTIVE: To report initial experience with laparoscopic radical cystectomy in 43 patients with invasive bladder carcinoma.
  • METHODS: From December 2003 to October 2006, 29 men and 14 women underwent laparoscopic radical cystectomy with extracorporeal-assisted urinary diversion for transitional cell carcinoma of the bladder (n=40), adenocarcinoma (n=2) and squamous cell arcinoma (n=1).
  • CONCLUSIONS: We demonstrate that the combination of laparoscopic radical cystectomy and extracorporeal urinary diversion is possible and remains a safe, feasible, and repeatable surgical technique.
  • The laparoscopic surgery with extracorporeal urinary reconstruction is emerging as a viable alternative to open radical cystectomy while characterized by less trauma, short recovery time and low complications.
  • [MeSH-major] Cystectomy / methods. Laparoscopy. Urinary Bladder Neoplasms / surgery
  • [MeSH-minor] Aged. Female. Follow-Up Studies. Humans. Male. Middle Aged. Treatment Outcome. Urinary Diversion / methods

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18844055.001).
  • [ISSN] 0529-5815
  • [Journal-full-title] Zhonghua wai ke za zhi [Chinese journal of surgery]
  • [ISO-abbreviation] Zhonghua Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


38. Cathomas R, Geldart TR, Iveson T, Singh N, Rowen D: An unusual differential diagnosis of penile warts: metastases from rectal carcinoma. Int J STD AIDS; 2006 Jul;17(7):491-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual differential diagnosis of penile warts: metastases from rectal carcinoma.
  • Their diagnosis is usually based on clinical observation and biopsy is not generally undertaken.
  • Penile metastases arise most frequently from genitourinary cancers (prostate, bladder and kidney), but may also arise from tumours of the large bowel; other primary sites are extremely uncommon.
  • [MeSH-major] Adenocarcinoma / secondary. Penile Neoplasms / secondary. Penis / pathology. Rectal Neoplasms / pathology. Warts / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Humans. Male. Middle Aged. Penile Diseases / diagnosis. Penile Diseases / pathology

  • MedlinePlus Health Information. consumer health - Warts.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16820084.001).
  • [ISSN] 0956-4624
  • [Journal-full-title] International journal of STD & AIDS
  • [ISO-abbreviation] Int J STD AIDS
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


39. Lughezzani G, Sun M, Jeldres C, Alasker A, Budäus L, Shariat SF, Latour M, Widmer H, Duclos A, Jolivet-Tremblay M, Montorsi F, Perrotte P, Karakiewicz PI: Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality. Urology; 2010 Feb;75(2):376-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
  • OBJECTIVES: To compare stage at radical cystectomy (RC) and cancer-specific mortality (CSM) after RC between non-urachal adenocarcinoma (ADK) and urothelial carcinoma (UC) of the urinary bladder.
  • After adjustment for all covariates, including stage and grade, ADK was not associated with worse prognosis than UC (hazard ratio, 1.05; P = .6).
  • [MeSH-major] Adenocarcinoma / mortality. Adenocarcinoma / pathology. Carcinoma, Transitional Cell / mortality. Carcinoma, Transitional Cell / pathology. Cystectomy. Urinary Bladder Neoplasms / mortality. Urinary Bladder Neoplasms / pathology

  • Genetic Alliance. consumer health - Bladder cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010. Published by Elsevier Inc.
  • (PMID = 20022091.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


40. Hirata K, Kanemitsu S, Nakayama Y, Nagata N, Itoh H, Ohnishi H, Ishikawa H, Furukawa Y, HNPCC registry and genetic testing project of the Japanese Society for Cancer of the Colon and Rectum (JSCCR): A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma. Am J Gastroenterol; 2006 Jan;101(1):193-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma.
  • BACKGROUND: One of the clinical features of hereditary nonpolyposis colorectal cancer (HNPCC) is a high incidence of multiple primary neoplasms arising in various organs including the gastrointestinal and genitourinary tracts.
  • METHODS AND RESULTS: A 40-yr-old Japanese patient, who had a past history of adenocarcinoma of the rectum and transitional cell carcinoma of the urinary bladder, developed a liposarcoma in his left thigh.
  • Although his family history did not fulfill the revised Amsterdam criteria, his blood sample was subjected to genetic testing.
  • Direct sequencing of the genomic DNA from the blood identified an AT deletion at codon 677 in exon 13 of hMSH2, a pathogenic mutation that has not been reported before.
  • The expression of MSH2 in the liposarcoma and rectal cancer of the patient was analyzed by immunohistochemistry, which revealed loss of MSH2 expression in the tumors.
  • Since an immunohistochemical analysis showed no nuclear staining for MSH2 protein in the liposarcoma as well as the rectal cancer, the loss of wild-type MSH2 protein was thus considered to possibly play a role in the development of liposarcoma in HNPCC patients.
  • [MeSH-major] Colorectal Neoplasms, Hereditary Nonpolyposis / genetics. Liposarcoma / pathology. Muscle Neoplasms / pathology. MutS Homolog 2 Protein / genetics. Neoplasms, Multiple Primary / pathology. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Adult. Base Pair Mismatch. Carcinoma, Transitional Cell / diagnosis. Carcinoma, Transitional Cell / pathology. Follow-Up Studies. Germ-Line Mutation. Humans. Male. Risk Assessment


41. Mazzucchelli R, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R: Immunohistochemical expression of prostate stem cell antigen in cystoprostatectomies with incidental prostate cancer. Int J Immunopathol Pharmacol; 2009 Jul-Sep;22(3):755-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunohistochemical expression of prostate stem cell antigen in cystoprostatectomies with incidental prostate cancer.
  • High expression of prostate stem cell antigen (PSCA) has been shown to be associated with adverse prognostic features in clinically-diagnosed prostate cancer.
  • PSCA expression was evaluated immunohistochemically in normal-looking epithelium (NEp), high-grade prostatic intraepithelial neoplasia (HGPIN) and pT2a Gleason score 6 acinar adenocarcinoma.
  • The evaluation was carried out on 20 cystoprostatectomies (CyPs) with incidental PCa from men with bladder urothelial carcinoma (UC), and 20 radical prostatectomies (RPs) with hormonally untreated PCa from men with clinically detected PCa.
  • In the CyPs the percentages of PSCA and Ki67 positive cells were lower than in the RPs, the differences between the CyP and RP compartments being not statistically significant.
  • However, there are no significant differences between CyPs with incidental prostate carcinoma and RPs with clinically diagnosed cancer.
  • [MeSH-major] Adenocarcinoma / immunology. Carcinoma, Acinar Cell / immunology. Immunohistochemistry. Incidental Findings. Membrane Glycoproteins / analysis. Neoplasm Proteins / analysis. Prostatic Intraepithelial Neoplasia / immunology. Prostatic Neoplasms / immunology. Urinary Bladder Neoplasms / immunology

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19822092.001).
  • [ISSN] 0394-6320
  • [Journal-full-title] International journal of immunopathology and pharmacology
  • [ISO-abbreviation] Int J Immunopathol Pharmacol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / GPI-Linked Proteins; 0 / Ki-67 Antigen; 0 / Membrane Glycoproteins; 0 / Neoplasm Proteins; 0 / PSCA protein, human
  •  go-up   go-down


42. Donate Moreno MJ, Giménez Bachs JM, Salinas Sánchez AS, Lorenzo Romero JG, Segura Martín M, Hernández Millán I, Pastor Guzmán JM, Ruiz Mondéjar R, Virseda Rodríguez J: [Urachal pathology: an overview review and report of three clinical cases]. Actas Urol Esp; 2005 Mar;29(3):332-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Patología del uraco: revisión de conjunto y presentación de tres casos.
  • With the use of these two clinical cases (cyst and urachal adenocarcinoma) we did an overview of the urachal pathology.
  • The urachal adenocarcinoma is a rare pathology, it usually exhibit hematuria and we need to follow the same diagnostic tools as we use in vesical tumors (cystoscopy and transurethral vesical resection).
  • Adenocarcinoma of the dome of the bladder is the main differential diagnosis.
  • [MeSH-major] Adenocarcinoma. Urachal Cyst. Urachus

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15945263.001).
  • [ISSN] 0210-4806
  • [Journal-full-title] Actas urologicas espanolas
  • [ISO-abbreviation] Actas Urol Esp
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


43. Lim M, Adsay NV, Grignon D, Osunkoya AO: Urothelial carcinoma with villoglandular differentiation: a study of 14 cases. Mod Pathol; 2009 Oct;22(10):1280-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumors of the urinary bladder may have a variety of histological patterns.
  • However, urothelial carcinomas with both villous and glandular features have not been well characterized.
  • A concurrent high-grade papillary urothelial carcinoma component was identified in 11 cases (79%), micropapillary component in 5 (36%) cases, in-situ urothelial carcinoma component in 3 cases (21%), plasmacytoid component in 3 cases (21%), invasive adenocarcinoma in 2 cases, sarcomatoid carcinoma component in one case (14%), and small-cell carcinoma component in 1 case (7%).
  • [MeSH-major] Carcinoma / pathology. Cell Differentiation. Neoplasms, Glandular and Epithelial / pathology. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Aged. Aged, 80 and over. Biopsy. Carcinoma in Situ / pathology. Carcinoma, Small Cell / pathology. Female. Humans. Male. Middle Aged. Neoplasm Invasiveness. Urothelium / pathology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19593329.001).
  • [ISSN] 1530-0285
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Srivastava K, Singh S, Srivastava M, Srivastava AN: Incisional skin metastasis of a squamous cell cervical carcinoma 3.5 years after radical treatment--a case report. Int J Gynecol Cancer; 2005 Nov-Dec;15(6):1183-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Most commonly metastatic skin incisional cancers have been reported with cancers of colon, kidney, and bladder.
  • It has been reported in few patients with adenocarcinoma and poorly differentiated histopathology, more so at drain site postoperatively.
  • She received salvage chemotherapy; however, she did not show any response and finally succumbed to the disease.


45. Ballardini P, Margutti G, Zangirolami A, Tampieri M, Incasa E, Gamberini S, Manfredini R: Cardiac tamponade as unusual presentation of underlying unrecognized cancer. Am J Emerg Med; 2007 Jul;25(6):737.e5-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cardiac tamponade as unusual presentation of underlying unrecognized cancer.
  • [MeSH-minor] Adenocarcinoma / complications. Adenocarcinoma / secondary. Carcinoma, Non-Small-Cell Lung / complications. Carcinoma, Non-Small-Cell Lung / diagnosis. Carcinoma, Non-Small-Cell Lung / secondary. Fatal Outcome. Humans. Lung Neoplasms / complications. Lung Neoplasms / diagnosis. Male. Middle Aged. Pericardial Effusion / diagnosis. Pericardial Effusion / etiology. Urinary Bladder Neoplasms / complications. Urinary Bladder Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Pericardial Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17606115.001).
  • [ISSN] 1532-8171
  • [Journal-full-title] The American journal of emergency medicine
  • [ISO-abbreviation] Am J Emerg Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


46. Reyes Ojeda MD, López Aznar DJ, Abreu Sánchez P, Uruburu Garcia E, Martínez Carsi C, Sopena Monforte R: [Bronchioloalveolar carcinoma as potencial cause of false negative with PET-FDG]. Rev Esp Med Nucl; 2005 Jul-Aug;24(4):254
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Carcinoma bronquioloalveolar como causa potencial de falso negativo con PET-FDG.
  • [MeSH-major] Adenocarcinoma, Bronchiolo-Alveolar / radionuclide imaging. Adenocarcinoma, Mucinous / radionuclide imaging. Fluorodeoxyglucose F18. Lung Neoplasms / radionuclide imaging. Neoplasms, Second Primary / radionuclide imaging. Positron-Emission Tomography. Radiopharmaceuticals
  • [MeSH-minor] Carcinoma, Transitional Cell / pathology. Carcinoma, Transitional Cell / secondary. Diagnosis, Differential. Humans. Male. Middle Aged. Urinary Bladder Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16122411.001).
  • [ISSN] 0212-6982
  • [Journal-full-title] Revista española de medicina nuclear
  • [ISO-abbreviation] Rev Esp Med Nucl
  • [Language] spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


47. Patel H, Joseph JV, Amodeo A, Kothari K: Laparoscopic salvage total pelvic exenteration: Is it possible post-chemo-radiotherapy? J Minim Access Surg; 2009 Oct;5(4):111-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Indications for total pelvic exenteration in a male (removal of the bladder, prostate and rectum) and in a woman (removal bladder, uterus, vagina, ovaries and rectum) are rare.
  • We report the first two cases of a salvage laparoscopic total pelvic exenteration in a male for rectal adenocarcinoma invading into the bladder and prostate, post-chemo-radiotherapy and in a woman for squamous cell carcinoma of cervix invading the bladder and rectum post-chemo-radiotherapy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Obstet Gynecol. 1975 Apr 1;121(7):907-18 [1115180.001]
  • [Cites] Surg Clin North Am. 1969 Apr;49(2):431-47 [4886910.001]
  • [Cites] Cancer. 1948 Jul;1(2):177-83 [18875031.001]
  • [Cites] Gynecol Oncol. 2006 Dec;103(3):1023-30 [16890276.001]
  • [Cites] Gynecol Oncol. 2005 Oct;99(1):153-9 [16054678.001]
  • [Cites] Int J Gynecol Cancer. 2005 Jul-Aug;15(4):624-9 [16014116.001]
  • [Cites] Int J Gynecol Cancer. 2005 May-Jun;15(3):475-82 [15882172.001]
  • [Cites] Surg Oncol Clin N Am. 2005 Apr;14(2):289-300 [15817240.001]
  • [Cites] Semin Surg Oncol. 1999 Oct-Nov;17(3):161-7 [10504663.001]
  • [Cites] Lancet. 2002 Jun 29;359(9325):2224-9 [12103285.001]
  • [Cites] Ann Surg Oncol. 1998 Jul-Aug;5(5):399-406 [9718168.001]
  • [Cites] Gynecol Oncol. 1997 Jan;64(1):130-5 [8995561.001]
  • [Cites] Gynecol Oncol. 1995 Feb;56(2):207-10 [7896187.001]
  • [Cites] Gynecol Oncol. 1988 Sep;31(1):205-16 [3410348.001]
  • [Cites] Am J Obstet Gynecol. 1985 May 1;152(1):12-6 [2581447.001]
  • [Cites] Obstet Gynecol. 1989 Dec;74(6):934-43 [2586960.001]
  • [Cites] Gynecol Oncol. 2003 Nov;91(2):369-77 [14599868.001]
  • [Cites] Gynecol Oncol. 2002 Sep;86(3):311-5 [12217753.001]
  • [Cites] Semin Surg Oncol. 1999 Apr-May;16(3):236-41 [10225302.001]
  • [Cites] Gynecol Oncol. 1989 Oct;35(1):93-8 [2792911.001]
  • [Cites] Am J Obstet Gynecol. 1977 Dec 15;129(8):881-92 [930972.001]
  • [Cites] Gynecol Oncol. 1989 Jun;33(3):279-82 [2722049.001]
  • [Cites] Obstet Gynecol. 1989 Jun;73(6):1027-34 [2726106.001]
  • (PMID = 20407571.001).
  • [ISSN] 1998-3921
  • [Journal-full-title] Journal of minimal access surgery
  • [ISO-abbreviation] J Minim Access Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2843126
  • [Keywords] NOTNLM ; Laparoscopy / malignancy / pelvic exenteration
  •  go-up   go-down


48. Takada S, Yoshikawa M, Hosokawa Y, Hayashi Y, Fujimoto K, Hirao Y: [Small cell carcinoma of the urinary bladder detected by urinary cytology : a case report]. Hinyokika Kiyo; 2010 Mar;56(3):173-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Small cell carcinoma of the urinary bladder detected by urinary cytology : a case report].
  • A computerized tomography scan revealed a bladder tumor (cT3bN0M0), and urinary cytology demonstrated neuroendocrine carcinoma.
  • He underwent transurethral resection of bladder tumor and needle biopsy of the prostate.
  • Pathological examination demonstrated small cell carcinoma in the bladder tumor specimen and well differentiated adenocarcinoma (cT1c) with a Gleason score of 34 in the prostatic specimen.
  • He did not receive adjuvant chemotherapy because of the poor postoperative systemic condition and he died of acute myocardial infarction 5 months later.
  • [MeSH-major] Carcinoma, Small Cell / pathology. Urinary Bladder Neoplasms / pathology. Urine / cytology


49. Fung AY, Enke CA, Ayyangar KM, Thompson RB, Zhen W, Raman NV, Djajaputra D, Li S, Nehru RM, Pillai S, Sourivong P, Headley M, Yager AL: Effects of field parameters on IMRT plan quality for gynecological cancer: a case study. J Appl Clin Med Phys; 2005;6(3):46-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effects of field parameters on IMRT plan quality for gynecological cancer: a case study.
  • Traditional external beam radiotherapy of gynecological cancer consists of a 3D, four-field-box technique.
  • This is a case report of IMRT planning for a patient with endometrial cancer.
  • Delineated anatomical contours included the intrapelvic nodes (PTV), bone marrow, small bowel, bladder, rectum, sigmoid colon, periaortic nodes (PTV), spinal cord, left kidney, right kidney, large bowel, liver, and tissue (excluding the PTVs).
  • Compared with the 3D plan, the IMRT plan had superior dose conformity and spared the bladder and sigmoid colon embedded in the intrapelvic nodes.
  • The number of segments did not have much effect on isodose distribution, but a reasonable number of segments was necessary to keep treatment time from being prohibitively long.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16143791.001).
  • [ISSN] 1526-9914
  • [Journal-full-title] Journal of applied clinical medical physics
  • [ISO-abbreviation] J Appl Clin Med Phys
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


50. Miller JS, Epstein JI: Noninvasive urothelial carcinoma of the bladder with glandular differentiation: report of 24 cases. Am J Surg Pathol; 2009 Aug;33(8):1241-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Noninvasive urothelial carcinoma of the bladder with glandular differentiation: report of 24 cases.
  • Noninvasive urothelial carcinoma (UC) with glandular differentiation in the absence of infiltrating carcinoma is a rare entity that has not been well characterized.
  • We retrieved 24 cases of noninvasive UC of the bladder with glandular differentiation on biopsy (n=20) or transurethral resection (n=4) without an associated invasive component.
  • Mean patient age at diagnosis was 70 years (range: 48 to 87 y) and 75% were male.
  • One case was a recent diagnosis, and 5 patients either refused treatment or were lost to follow-up.
  • Of the 18 patients with available follow-up information, 9 (50%) did not develop invasive carcinoma; the remaining 9 (50%) eventually developed an invasive bladder tumor.
  • Of these, 2 were small cell carcinoma, 3 were poorly-differentiated UC (2 of these developed widespread metastases), and 4 were UC, not otherwise specified.
  • Of note, none of the patients in the study developed invasive adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / pathology. Urinary Bladder Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19440144.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


51. Macdonald DM, Lin LL, Biehl K, Mutic S, Nantz R, Grigsby PW: Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer. Int J Radiat Oncol Biol Phys; 2008 Jun 1;71(2):618-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer.
  • PURPOSE: This treatment planning study compared pseudo-step-wedge intensity modulation (PSWIM), intensity-modulated radiation therapy (IMRT), and conventional external irradiation, all combined with brachytherapy, for treatment of patients with cervical cancer.
  • Total doses to Points A, Point P, the bladder point, and the rectal point were calculated.
  • RESULTS: The mean PSWIM total low-dose-rate equivalent dose to Points A and P (97.3 Gy and 65.1 Gy, respectively) was significantly higher, the mean rectal dose was the same, and the mean bladder dose was higher than with IMRT or four-field box.
  • Maximum bladder point doses are higher.
  • [MeSH-minor] Adenocarcinoma / radiotherapy. Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / radiotherapy. Feasibility Studies. Female. Humans. Lymphatic Irradiation / methods. Middle Aged. Pelvis. Prospective Studies. Radiation Injuries / pathology. Radiotherapy Dosage. Rectum. Urinary Bladder


52. Parikh B, Trivedi P, Ohri A, Shukla K, Desai S: Primary mucinous carcinoma of urachus--a case report. Indian J Pathol Microbiol; 2006 Jul;49(3):409-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Urachus. Urinary Bladder / pathology. Urinary Bladder Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17001902.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


53. Dickson BC, Fornasier VL, Streutker CJ, Stewart RJ: Ureteric obstruction: an unusual presentation of metastatic colon carcinoma. Can J Urol; 2007 Apr;14(2):3526-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present the case of a 78-year-old male who presented to clinic for follow-up of a papillary transitional cell carcinoma of the urinary bladder.
  • Notably, the patient also had a history of colorectal resection for an adenocarcinoma.
  • Upon surgical resection the lesion was found to be an adenocarcinoma, morphologically consistent with a metastasis from the patient's primary colonic adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / secondary. Colonic Neoplasms / pathology. Ureteral Neoplasms / secondary. Ureteral Obstruction / etiology
  • [MeSH-minor] Aged. Carcinoma, Transitional Cell / pathology. Humans. Male. Neoplasms, Second Primary. Urinary Bladder Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17466162.001).
  • [ISSN] 1195-9479
  • [Journal-full-title] The Canadian journal of urology
  • [ISO-abbreviation] Can J Urol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Canada
  •  go-up   go-down


54. Kulkarni JN, Gorasia TK, Choudhary JP, Mahajan PP: Endometrioid carcinoma of the upper urinary tract. J Cancer Res Ther; 2010 Oct-Dec;6(4):578-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endometrioid carcinoma of the upper urinary tract.
  • Herein, we report a second case of endometrioid carcinoma of the upper urinary tract presenting 17 years after hysterectomy for high grade adenocarcinoma of ovary.
  • After complete work up, she underwent right radical nephro-ureterectomy with bladder cuff excision.
  • The histology showed endometrioid carcinoma of upper urinary tract without any evidence of endometriosis.
  • [MeSH-major] Endometrial Neoplasms / diagnosis. Urologic Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21358108.001).
  • [ISSN] 1998-4138
  • [Journal-full-title] Journal of cancer research and therapeutics
  • [ISO-abbreviation] J Cancer Res Ther
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


55. Yamada T, Mori H, Kanemura M, Ohmichi M, Shibayama Y: Endometrial carcinoma with choriocarcinomatous differentiation: a case report and review of the literature. Gynecol Oncol; 2009 May;113(2):291-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Choriocarcinomas unrelated to pregnancy, teratomas, or germ cell tumors have been found in the stomach, lungs, colon, esophagus, bladder, breast, renal pelvis and other sites.
  • She received surgery and chemotherapy for endometrial adenocarcinoma.
  • CONCLUSION: Treatment and follow-up must be performed not only for the adenocarcinoma element but also for the choriocarcinoma element in patients presenting with endometrial carcinoma with choriocarcinomatous differentiation.
  • [MeSH-minor] Adenocarcinoma / drug therapy. Adenocarcinoma / pathology. Adenocarcinoma / surgery. Female. Humans. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19232701.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Fernández Rivera C, Alonso Hernández Á, Mosquera Reboredo J, Rodríguez Gómez I: Association of bladder adenocarcinoma and BK virus infection in a pancreatico-renal transplant recipient. NDT Plus; 2010 Jun;3(3):300-302
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association of bladder adenocarcinoma and BK virus infection in a pancreatico-renal transplant recipient.
  • We report a case of urinary bladder adenocarcinoma in a pancreatico-renal transplant recipient which was diagnosed 2 years after BKV infection.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pediatr Transplant. 2008 Aug;12(5):600-5 [18652620.001]
  • [Cites] Oncogene. 2006 May 4;25(19):2727-35 [16547506.001]
  • [Cites] Transplantation. 2008 Apr 15;85(7 Suppl):S42-8 [18401263.001]
  • [Cites] NDT Plus. 2009 Jun;2(3):246-9 [25984002.001]
  • [Cites] Oncogene. 2003 Aug 11;22(33):5192-200 [12910256.001]
  • [Cites] Virus Res. 1989 Apr;12(4):315-30 [2543158.001]
  • [Cites] J Am Soc Nephrol. 2004 Jun;15(6):1582-8 [15153569.001]
  • [Cites] J Infect Dis. 2005 Oct 15;192(8):1349-54 [16170751.001]
  • [Cites] Transplantation. 2005 May 27;79(10):1277-86 [15912088.001]
  • [Cites] Transplantation. 2009 Mar 15;87(5):621-30 [19295303.001]
  • [Cites] Transplantation. 2008 Mar 27;85(6):850-4 [18360267.001]
  • [Cites] Transplantation. 2002 Jun 27;73(12):1933-6 [12131691.001]
  • (PMID = 28657060.001).
  • [ISSN] 1753-0784
  • [Journal-full-title] NDT plus
  • [ISO-abbreviation] NDT Plus
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; BK virus / kidney transplantation / renal transplantation / urinary bladder neoplasms
  •  go-up   go-down


57. Maletic V, Cerovic S, Lazic M, Stojanovic M, Stevanovic P: Synchronous and multiple transitional cell carcinoma of the bladder and urachal cyst. Int J Urol; 2008 Jun;15(6):554-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous and multiple transitional cell carcinoma of the bladder and urachal cyst.
  • Among urachal tumors, adenocarcinoma is most frequent, although other histological types can also be found.
  • The synchronous presentation of a urachal transitional cell tumor, along with recurrent superficial bladder tumors has not been reported previously.
  • We are reporting a 49-year-old male patient in whom transitional cell carcinoma of a urachal cyst was found with recurrent, multiple bladder tumors.
  • The diagnosis of urachal cyst tumor was established according to ultrasonography and computed tomography.
  • Most of the bladder tumors were resected transurethrally while open surgical excision of the urachal cyst with en bloc resection of the bladder dome was performed.
  • Recurrent bladder tumors were afterwards treated with Bacillus Calmette Guerin (BCG) instillations.
  • [MeSH-major] Carcinoma, Transitional Cell / complications. Neoplasms, Multiple Primary / complications. Urachal Cyst / complications. Urinary Bladder Neoplasms / complications

  • Genetic Alliance. consumer health - Transitional cell carcinoma.
  • Genetic Alliance. consumer health - Urachal cyst.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18489649.001).
  • [ISSN] 1442-2042
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


58. Moussa O, Yordy JS, Abol-Enein H, Sinha D, Bissada NK, Halushka PV, Ghoneim MA, Watson DK: Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. Cancer Res; 2005 Dec 15;65(24):11581-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer.
  • TXAS was among the genes we identified based on its overexpression in invasive bladder tumors.
  • TXAS is overexpressed in common forms of bladder tumors: 69 of 97 (71.1%) transitional cell carcinoma (TCC), 38 of 53 (71.6%) squamous cell carcinoma, and 5 of 11 (45.5%) adenocarcinoma relative to nontumor tissue.
  • TXAS mRNA expression was found to be an independent prognostic marker for patients with bladder cancer.
  • Treatment of bladder cancer cell lines (T24 and TCC-SUP) with TXAS inhibitors and TXA(2) (TP) receptor antagonists reduced cell growth, migration, and invasion, whereas TP agonists stimulated cell migration and invasion.
  • [MeSH-major] Gene Expression Regulation, Neoplastic. Thromboxane-A Synthase / metabolism. Urinary Bladder Neoplasms / enzymology
  • [MeSH-minor] Adenocarcinoma / enzymology. Adenocarcinoma / genetics. Adenocarcinoma / pathology. Adult. Carcinoma, Squamous Cell / enzymology. Carcinoma, Squamous Cell / genetics. Carcinoma, Squamous Cell / pathology. Carcinoma, Transitional Cell / enzymology. Carcinoma, Transitional Cell / genetics. Carcinoma, Transitional Cell / pathology. Cell Movement. Cell Proliferation. Female. Humans. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Prognosis. RNA, Messenger / genetics. RNA, Messenger / metabolism. Receptors, Thromboxane / agonists. Receptors, Thromboxane / antagonists & inhibitors. Receptors, Thromboxane / metabolism. Survival Rate

  • Genetic Alliance. consumer health - Bladder cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16357168.001).
  • [ISSN] 0008-5472
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA069222; United States / NCI NIH HHS / CA / R21 CA106570
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / Receptors, Thromboxane; EC 5.3.99.5 / Thromboxane-A Synthase
  •  go-up   go-down


59. Knottenbelt C, Mellor D, Nixon C, Thompson H, Argyle DJ: Cohort study of COX-1 and COX-2 expression in canine rectal and bladder tumours. J Small Anim Pract; 2006 Apr;47(4):196-200
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cohort study of COX-1 and COX-2 expression in canine rectal and bladder tumours.
  • [MeSH-major] Adenocarcinoma / veterinary. Carcinoma, Transitional Cell / veterinary. Dog Diseases / enzymology. Prostaglandin-Endoperoxide Synthases / genetics. Rectal Neoplasms / veterinary. Urinary Bladder Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16573762.001).
  • [ISSN] 0022-4510
  • [Journal-full-title] The Journal of small animal practice
  • [ISO-abbreviation] J Small Anim Pract
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] EC 1.14.99.1 / Cyclooxygenase 1; EC 1.14.99.1 / Cyclooxygenase 2; EC 1.14.99.1 / Prostaglandin-Endoperoxide Synthases
  •  go-up   go-down


60. Franco-Hernandez C, Martinez-Glez V, Arjona D, de Campos JM, Isla A, Gutierrez M, Vaquero J, Rey JA: EGFR sequence variations and real-time quantitative polymerase chain reaction analysis of gene dosage in brain metastases of solid tumors. Cancer Genet Cytogenet; 2007 Feb;173(1):63-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Clinical response to Gefitinib (Iressa, ZD1839) has been found to be associated with somatic mutations, primarily of exons 18-21, of the epidermal growth factor receptor gene (EGFR) in non-small cell lung cancer (NSCLC).
  • The metastases derived from malignant melanoma (three cases), lung carcinoma (six cases), breast carcinoma (three cases), ovarian carcinoma (two cases), and one each from colon, kidney, bladder, and undifferentiated carcinoma.
  • These mutations presented in lesions derived from kidney carcinoma and lung adenocarcinoma.
  • These findings suggest that EGFR mutations and polymorphisms are not exclusively present in metastases derived from lung carcinoma.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17284372.001).
  • [ISSN] 0165-4608
  • [Journal-full-title] Cancer genetics and cytogenetics
  • [ISO-abbreviation] Cancer Genet. Cytogenet.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm; EC 2.7.10.1 / Receptor, Epidermal Growth Factor
  •  go-up   go-down


61. Giordano S, Taskinen S, Sankila A, Ala-Opas M: Adenocarcinoma in isolated rectal bladder after treatment of bladder exstrophy. Scand J Urol Nephrol; 2008;42(4):392-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma in isolated rectal bladder after treatment of bladder exstrophy.
  • We report the first Finnish patient with carcinoma in an augmented intestinal bladder, where urine and stools are not in contact.
  • The patient had undergone rectal bladder reconstruction at the age of 2 years because of bladder exstrophy.
  • When the patient was aged 46 years, a 2-cm, papillar, well-differentiated adenocarcinoma was detected and removed, preserving the rectal bladder.
  • [MeSH-major] Adenocarcinoma / diagnosis. Bladder Exstrophy. Urinary Bladder Neoplasms / diagnosis
  • [MeSH-minor] Child, Preschool. Humans. Male. Rectum / surgery. Urinary Bladder / abnormalities. Urinary Bladder / surgery

  • Genetic Alliance. consumer health - Exstrophy of the Bladder.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19230174.001).
  • [ISSN] 0036-5599
  • [Journal-full-title] Scandinavian journal of urology and nephrology
  • [ISO-abbreviation] Scand. J. Urol. Nephrol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Sweden
  •  go-up   go-down


62. Sung MT, Lopez-Beltran A, Eble JN, MacLennan GT, Tan PH, Montironi R, Jones TD, Ulbright TM, Blair JE, Cheng L: Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder. Mod Pathol; 2006 Nov;19(11):1395-401
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder.
  • Intestinal metaplasia has been proposed to be a precursor lesion of adenocarcinoma in the urinary bladder.
  • Tissues from 46 patients, including 22 cases of intestinal metaplasia of the urinary bladder, 11 cases of typical cystitis glandularis, and 13 cases containing both lesions, were selected and immunohistochemical stains for CDX2, Hep, cytokeratin 20 (CK20), and cytokeratin 7 (CK7) were performed.
  • Nuclear staining for CDX2 was observed in 29 of 35 (83%) cases of intestinal metaplasia of the urinary bladder.
  • In contrast, nuclear staining for CDX2 was not observed in any case of typical cystitis glandularis; however, seven of 24 (29%) cases showed aberrant cytoplasmic expression in a mean of 37% of cells.
  • In the urinary bladder, intestinal metaplasia and typical cystitis glandularis have sharply contrasting immunoprofiles.
  • Additionally, the absence of Hep staining in intestinal metaplasia of the urinary bladder, despite its morphologic resemblance to normal colonic mucosa and intestinal metaplasia in other organs, may signify the presence of unique metaplastic pathways in the urinary bladder.
  • [MeSH-major] Cystitis / pathology. Intestines / pathology. Precancerous Conditions / pathology. Urinary Bladder / pathology. Urinary Bladder Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16951671.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Autoantigens; 0 / CDX2 protein, human; 0 / Homeodomain Proteins; 0 / KRT20 protein, human; 0 / KRT7 protein, human; 0 / Keratin-20; 0 / Keratin-7
  •  go-up   go-down


63. Liang JJ, Zhu S, Bruggeman R, Zaino RJ, Evans DB, Fleming JB, Gomez HF, Zander DS, Wang H: High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev; 2010 Oct;19(10):2598-604
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
  • BACKGROUND: Stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, have been shown to mediate invasiveness and metastatic behavior in a number of cancers, including ovarian, prostate, bladder, breast, and pancreatic cancers.
  • The expression and significance of SDF-1 in pancreatic ductal adenocarcinoma (PDA) have not been systematically studied.

  • Genetic Alliance. consumer health - Factor II Deficiency.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] ©2010 AACR.
  • (PMID = 20732965.001).
  • [ISSN] 1538-7755
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA016672
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Chemokine CXCL12
  •  go-up   go-down


64. Parekh DJ, Lin WC, Herrell SD: Optical spectroscopy characteristics can differentiate benign and malignant renal tissues: a potentially useful modality. J Urol; 2005 Nov;174(5):1754-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: Promising results of optical signals have been reported in the literature for the diagnosis of Barrett's esophagus, oral cavity lesions, brain tumor margins, cervical intraepithelial neoplasia, skin cancer and bladder cancer.
  • The potential usefulness of these techniques in renal tissues and neoplasms has not been described to date.
  • [MeSH-major] Adenocarcinoma, Clear Cell / pathology. Carcinoma, Renal Cell / pathology. Kidney Neoplasms / pathology. Precancerous Conditions / pathology. Spectrometry, Fluorescence
  • [MeSH-minor] Case-Control Studies. Diagnosis, Differential. Female. Humans. Kidney / pathology. Male. Reference Values. Sampling Studies. Sensitivity and Specificity. Tissue Culture Techniques

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Urol. 2005 Nov;174(5):1723-4 [16217270.001]
  • (PMID = 16217277.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


65. Castillo CM, Ha CY, Gater DR, Grob BM, Klausner AP: Prophylactic radical cystectomy for the management of keratinizing squamous metaplasia of the bladder in a man with tetraplegia. J Spinal Cord Med; 2007;30(4):389-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prophylactic radical cystectomy for the management of keratinizing squamous metaplasia of the bladder in a man with tetraplegia.
  • BACKGROUND/OBJECTIVE: To report a case of keratinizing squamous metaplasia of the bladder treated with radical cystectomy.
  • METHODS: Keratinizing squamous metaplasia of the bladder is a rare entity that can result from chronic irritative stimuli involving the bladder.
  • A case report is presented describing the diagnosis and management of keratinizing squamous metaplasia of the bladder in a tetraplegic man with a chronic indwelling urinary catheter.
  • Final pathology revealed focal erosion and diffuse keratinizing squamous metaplasia of the bladder with prostatic adenocarcinoma as an incidental finding.
  • CONCLUSIONS: Patients with spinal cord injury who use indwelling catheters for bladder management are at higher risk of developing keratinizing squamous metaplasia.
  • An interdisciplinary approach is recommended before consideration of bladder resection.
  • [MeSH-major] Carcinoma, Squamous Cell / etiology. Carcinoma, Squamous Cell / surgery. Cystectomy / methods. Quadriplegia / complications. Urinary Bladder Neoplasms / etiology. Urinary Bladder Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Indian J Pathol Microbiol. 1994 Dec;37 Suppl:S39-40 [8613170.001]
  • [Cites] Arch Phys Med Rehabil. 1995 Aug;76(8):758-62 [7632132.001]
  • [Cites] J Urol. 1997 Jun;157(6):2115 [9146594.001]
  • [Cites] SCI Nurs. 1997 Sep;14(3):87-95 [9355615.001]
  • [Cites] J Clin Pathol. 1998 Aug;51(8):583-7 [9828815.001]
  • [Cites] Urology. 1999 Feb;53(2):292-7 [9933042.001]
  • [Cites] World J Urol. 1999 Aug;17(4):211-8 [10460403.001]
  • [Cites] Urol Clin North Am. 2005 May;32(2):207-16 [15862618.001]
  • [Cites] J Urol. 2005 Nov;174(5):1729-36 [16217273.001]
  • [Cites] Am J Surg Pathol. 2006 Jul;30(7):883-91 [16819332.001]
  • [Cites] Int Urol Nephrol. 1999;31(4):457-61 [10668940.001]
  • [Cites] Spinal Cord. 2001 Nov;39(11):568-70 [11641805.001]
  • [Cites] BJU Int. 2002 Sep;90(4):386-90 [12175394.001]
  • [Cites] Eur Urol. 2002 Oct;42(4):350-5 [12361900.001]
  • [Cites] Eur Urol. 2002 Nov;42(5):469-74 [12429156.001]
  • [Cites] J Spinal Cord Med. 2003 Winter;26(4):335-8 [14992333.001]
  • [Cites] Qual Life Res. 2004 Feb;13(1):97-110 [15058792.001]
  • [Cites] Rehabil Nurs. 2004 Jul-Aug;29(4):122-6 [15222093.001]
  • [Cites] J Urol. 1967 Aug;98(2):206-8 [6046997.001]
  • [Cites] Urology. 1975 Dec;6(6):759-61 [1202729.001]
  • [Cites] J Urol. 1977 Dec;118(6):967-71 [926277.001]
  • [Cites] J Urol. 1979 Sep;122(3):317-21 [470001.001]
  • [Cites] S Afr Med J. 1980 Nov 1;58(18):725-8 [7423317.001]
  • [Cites] J Urol. 1985 Jun;133(6):1034-5 [3999203.001]
  • [Cites] J Urol. 1997 Jun;157(6):2112-4 [9146593.001]
  • (PMID = 17853664.001).
  • [ISSN] 1079-0268
  • [Journal-full-title] The journal of spinal cord medicine
  • [ISO-abbreviation] J Spinal Cord Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2031939
  •  go-up   go-down


66. Pesce GA, Clivio A, Cozzi L, Nicolini G, Richetti A, Salati E, Valli M, Vanetti E, Fogliata A: Early clinical experience of radiotherapy of prostate cancer with volumetric modulated arc therapy. Radiat Oncol; 2010;5:54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Early clinical experience of radiotherapy of prostate cancer with volumetric modulated arc therapy.
  • V70Gy = 10.7 +/- 5.5% against an objective of < 25%) similarly for bladder (e.g.
  • CONCLUSION: RapidArc proved to be a safe, qualitative and advantageous treatment modality for prostate cancer.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Prostatic Neoplasms / radiotherapy. Radiotherapy, Intensity-Modulated / methods


67. Okabayashi T, Sun ZL, Montgomey RA, Hanazaki K: Surgical outcome of carcinosarcoma of the gall bladder: a review. World J Gastroenterol; 2009 Oct 21;15(39):4877-82
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical outcome of carcinosarcoma of the gall bladder: a review.
  • Carcinosarcoma, which comprises less than one percent of all gall bladder neoplasms, is characterized by the presence of variable proportions of carcinomatous and sarcomatous elements.
  • Recently, several reports have described patients suffering from carcinosarcoma of the gall bladder.
  • However, there are no large studies regarding the clinicopathologic features, therapeutic management, and surgical outcome of this disease because the number of patients who undergo resection of gall bladder carcinosarcoma at a single institution is limited.
  • A Medline search was performed using the keywords 'gall bladder' and 'carcinosarcoma'.
  • Optimal adjuvant chemotherapy and/or radiotherapy protocols for carcinosarcoma of the gall bladder have not been established.
  • The outcome of 36 patients who underwent surgical resection for carcinosarcoma of the gall bladder was poor; the 3-year overall survival rate was only 31.0% and the median survival time was 7.0 mo.
  • Since the postoperative prognosis of carcinosarcoma of the gall bladder is worse than that of adenocarcinoma, new adjuvant chemotherapies and/or radiation techniques are essential for improvement of surgical outcome.

  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Kurume Med J. 1999;46(3-4):175-9 [10659595.001]
  • [Cites] AJR Am J Roentgenol. 1996 May;166(5):1233-4 [8615287.001]
  • [Cites] Surg Today. 2002;32(5):462-7 [12061703.001]
  • [Cites] J Gastroenterol. 2002;37(11):966-71 [12483254.001]
  • [Cites] Gen Diagn Pathol. 1998 Apr;143(5-6):321-5 [9653915.001]
  • [Cites] Pathol Int. 2004 Nov;54(11):866-71 [15533231.001]
  • [Cites] J Gastroenterol. 2005 Feb;40(2):192-9 [15770404.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2005 Jun;17(6):683-5 [15879734.001]
  • [Cites] J Clin Gastroenterol. 2005 Jul;39(6):544-8 [15942444.001]
  • [Cites] J Gastrointest Surg. 2005 Jul-Aug;9(6):818-21 [15985237.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2006;13(5):468-71 [17013725.001]
  • [Cites] World J Gastroenterol. 2008 Nov 28;14(44):6765-70 [19058301.001]
  • [Cites] Surg Today. 2009;39(2):168-71 [19198999.001]
  • [Cites] Surg Today. 2009;39(3):241-6 [19280285.001]
  • [Cites] Exp Mol Med. 2009 Feb 28;41(2):102-15 [19287191.001]
  • [Cites] Indian J Pathol Microbiol. 2009 Apr-Jun;52(2):244-5 [19332928.001]
  • [Cites] World J Gastroenterol. 2009 Apr 21;15(15):1876-9 [19370786.001]
  • [Cites] Arch Pathol Lab Med. 2003 Oct;127(10):e406-8 [14521442.001]
  • [Cites] J Pathol. 1971 Jun;104(2):145-8 [5286390.001]
  • [Cites] Cancer. 1973 Aug;32(2):471-5 [4353018.001]
  • [Cites] Am J Clin Pathol. 1980 May;73(5):709-11 [6246794.001]
  • [Cites] Arch Pathol Lab Med. 1981 Jun;105(6):287-93 [6263212.001]
  • [Cites] Cancer. 1982 Sep 15;50(6):1166-70 [7104957.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1982;396(2):225-30 [6289513.001]
  • [Cites] Cancer. 1984 May 15;53(10):2171-7 [6704904.001]
  • [Cites] Histopathology. 1987 Feb;11(2):209-14 [2437004.001]
  • [Cites] Cancer. 1988 May 1;61(9):1872-9 [2451557.001]
  • [Cites] Acta Pathol Jpn. 1988 Jan;38(1):21-33 [2834912.001]
  • [Cites] Am Surg. 1988 Aug;54(8):492-4 [3395026.001]
  • [Cites] Cancer. 1990 Sep 1;66(5):992-7 [2386928.001]
  • [Cites] Am J Surg Pathol. 1993 Apr;17(4):415-21 [8494107.001]
  • [Cites] Hum Pathol. 1993 Dec;24(12):1298-305 [8276377.001]
  • [Cites] J Oral Pathol Med. 1994 May;23(5):232-6 [7519267.001]
  • [Cites] J Clin Gastroenterol. 1994 Jun;18(4):314-6 [8071517.001]
  • [Cites] Arch Pathol Lab Med. 1995 Mar;119(3):279-82 [7887785.001]
  • [Cites] Pathol Int. 1996 Jan;46(1):38-45 [10846548.001]
  • (PMID = 19842216.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Editorial; Review
  • [Publication-country] China
  • [Number-of-references] 38
  • [Other-IDs] NLM/ PMC2764963
  •  go-up   go-down


68. Puente S, Velasco A, Gallel P, Pallares J, Perez-Ruiz L, Ros S, Maravall J, Matias-Guiu X: Metastatic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder. Endocr Pathol; 2008;19(3):190-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder.
  • In some cases, demonstration of the primary tumor is not easy.
  • The primary tumor was a small cell carcinoma that occurred as a minor component in a transitional carcinoma of the urinary bladder.
  • The microscopical and immunohistochemical features of both tumors, in the thyroid and the bladder, were identical.
  • Moreover, both tumors exhibited an identical mutation in p53, as well as similar loss of heterozygosity at 10q23 and RASSF1A promoter hypermethylation, clearly indicating that the bladder tumor was the site for the primary tumor of the patient.
  • [MeSH-major] Carcinoma, Small Cell / genetics. Carcinoma, Small Cell / secondary. Thyroid Neoplasms / genetics. Thyroid Neoplasms / secondary. Urinary Bladder Neoplasms / genetics. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Base Sequence. Carcinoma, Transitional Cell / pathology. DNA Methylation. DNA Mutational Analysis. Humans. Immunohistochemistry. Loss of Heterozygosity. Male. Middle Aged. Neoplasms, Multiple Primary / pathology. Promoter Regions, Genetic / genetics. Prostatic Neoplasms / pathology. Tumor Suppressor Protein p53 / genetics. Tumor Suppressor Proteins / genetics

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1997 Jul;21(7):754-62 [9236831.001]
  • [Cites] Int J Oncol. 1999 Nov;15(5):927-34 [10536175.001]
  • [Cites] J Endocrinol Invest. 2005 Apr;28(4):371-8 [15966513.001]
  • [Cites] Am J Surg Pathol. 1980 Aug;4(4):333-41 [6999920.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1990;417(3):267-71 [2166978.001]
  • [Cites] Ann Intern Med. 1988 Sep 1;109(5):364-71 [2841895.001]
  • [Cites] Hum Pathol. 2005 Jul;36(7):718-23 [16084939.001]
  • [Cites] Cancer. 2005 Mar 15;103(6):1172-8 [15700264.001]
  • [Cites] Hum Pathol. 1989 Sep;20(9):896-902 [2550350.001]
  • [Cites] Int J Gynecol Pathol. 2002 Jul;21(3):268-72 [12068173.001]
  • [Cites] Anticancer Res. 2005 May-Jun;25(3B):2001-4 [16158936.001]
  • [Cites] Cancer. 2004 Sep 1;101(5):957-62 [15329903.001]
  • [Cites] Int J Exp Pathol. 2005 Aug;86(4):213-8 [16045543.001]
  • (PMID = 18446450.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RASSF1 protein, human; 0 / Tumor Suppressor Protein p53; 0 / Tumor Suppressor Proteins
  •  go-up   go-down


69. Lian J, Dundas G, Carlone M, Ghosh S, Pearcey R: Twenty-year review of radiotherapy for vaginal cancer: an institutional experience. Gynecol Oncol; 2008 Nov;111(2):298-306
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Twenty-year review of radiotherapy for vaginal cancer: an institutional experience.
  • OBJECTIVE: To evaluate clinical outcome, prognostic factors and chronic morbidity with radiotherapy for vaginal cancer treatment.
  • MATERIALS AND METHODS: 68 patients with vaginal cancer treated by radical or adjuvant radiotherapy (RT) were selected.
  • Five with rare subtypes of histopathology and 8 with adenocarcinoma were excluded from this study.
  • Late radiation toxicity was minimal in the bladder (4.6%) and bowel (4.6%).
  • CONCLUSION: This retrospective review suggested that tumor stage, site, and size were important prognostic factors in patients with vaginal cancer.

  • Genetic Alliance. consumer health - Vaginal cancer.
  • MedlinePlus Health Information. consumer health - Vaginal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18722657.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


70. Pentheroudakis G, Golfinopoulos V, Pavlidis N: Switching benchmarks in cancer of unknown primary: from autopsy to microarray. Eur J Cancer; 2007 Sep;43(14):2026-36
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
  • INTRODUCTION: Cancer of unknown primary (CUP) is associated with unknown biology and dismal prognosis.
  • A primary was identified in 644 (73%) of them, mostly in the lung (27%), pancreas (24%), hepatobiliary tree (8%), kidneys (8%), bowel, genital system and stomach, as a small focus of adenocarcinoma or poorly differentiated carcinoma.
  • Between the 1944-1980 and the 1980-2000 series, female representation increased, 'undetermined neoplasm' diagnosis became rarer, pancreatic primaries were found less often while colonic ones were identified more frequently.
  • Four studies using microarray technology profiled more than 500 CUP cases using classifier set of genes (ranging from 10 to 495) and reported strikingly dissimilar frequencies of assigned primary sites (lung 11.5%, pancreas 12.5%, bowel 12%, breast 15%, hepatobiliary tree 8%, kidneys 6%, genital system 9%, bladder 5%) in 75-90% of the cases.
  • [MeSH-major] Microarray Analysis / methods. Neoplasms, Unknown Primary / diagnosis

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17698346.001).
  • [ISSN] 0959-8049
  • [Journal-full-title] European journal of cancer (Oxford, England : 1990)
  • [ISO-abbreviation] Eur. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


71. De E, Pisters LL, Pettaway CA, Scott S, Westney OL: Salvage prostatectomy with bladder neck closure, continent catheterizable stoma and bladder augmentation: feasibility and patient reported continence outcomes at 32 months. J Urol; 2007 Jun;177(6):2200-4; discussion 2204
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Salvage prostatectomy with bladder neck closure, continent catheterizable stoma and bladder augmentation: feasibility and patient reported continence outcomes at 32 months.
  • PURPOSE: Salvage prostatectomy after radiation therapy is associated with a high rate of urinary incontinence.
  • To avoid this outcome in candidates with preexisting voiding symptoms, such as frequency, urgency and urge incontinence, we performed concurrent bladder augmentation with bladder neck closure and a catheterizable stoma.
  • Urinary incontinence and patient satisfaction were evaluated.
  • MATERIALS AND METHODS: Between October 2000 and February 2003, 11 patients underwent salvage prostatectomy with bladder neck closure and ileal augmentation using catheterizable appendicovesicostomy or Monti ileovesicostomy.
  • RESULTS: The indication for surgery was recurrent adenocarcinoma of the prostate in 10 patients and invasive squamous cell carcinoma of the urethra in 1.
  • CONCLUSIONS: Continent catheterizable bladder augmentation is a technically feasible option for men requiring salvage prostatectomy.
  • [MeSH-major] Adenocarcinoma / surgery. Cystostomy. Prostatectomy. Prostatic Neoplasms / surgery. Salvage Therapy. Urinary Incontinence / surgery
  • [MeSH-minor] Aged. Feasibility Studies. Follow-Up Studies. Humans. Male. Middle Aged. Patient Satisfaction. Surveys and Questionnaires. Treatment Outcome. Urinary Catheterization

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • MedlinePlus Health Information. consumer health - Urinary Incontinence.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17509319.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


72. Farhat MH, Moumneh G, Jalloul R, El Hout Y: Secondary adenocarcinoma of the urinary bladder from a primary gastric cancer. J Med Liban; 2007 Jul-Sep;55(3):162-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Secondary adenocarcinoma of the urinary bladder from a primary gastric cancer.
  • Primary bladder tumor is a frequent urological malignancy, whereas the incidence of secondary bladder tumor from a distant organ is quite rare.
  • Secondary bladder neoplasms represent no more than 3% of all malignant bladder tumors in surgical specimens, of which distant metastases from stomach account for about 4%.
  • The signs of bladder neoplasm in a patient with malignancy elsewhere should alarm the clinician for a possible metastatic origin.
  • We present a patient with primary adenocarcinoma of the stomach, who underwent total gastrectomy and received adjuvant chemotherapy, and was diagnosed with metastasis to the urinary bladder 15 months later.
  • We review the epidemiology of secondary adenocarcinoma of the bladder, mechanisms of metastasis, associated common primaries with focus on gastric malignancies, radiological findings, and role of immunohistochemical staining.
  • [MeSH-major] Adenocarcinoma / secondary. Stomach Neoplasms / pathology. Urinary Bladder Neoplasms / secondary

  • Genetic Alliance. consumer health - Bladder cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Med Liban. 2008 Jan-Mar;56(1):48 [19534093.001]
  • (PMID = 17966739.001).
  • [ISSN] 0023-9852
  • [Journal-full-title] Le Journal médical libanais. The Lebanese medical journal
  • [ISO-abbreviation] J Med Liban
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Lebanon
  • [Number-of-references] 16
  •  go-up   go-down


73. Kwiatkowski M, Paśnik K, Orłowski M, Furga P: [Therapeutic and diagnostic problems in a patient with a pelvic tumour--case report]. Pol Merkur Lekarski; 2009 May;26(155):496-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Colorectal cancer has become the commonest form of cancer in gastrointestinal (GI) tract and nowadays it is the second cause of death among all malignant tumours.
  • Bladder cancer is the fourth commonest tumour in males and eighth in females.
  • Despite repeated colon and bladder biopsies no malignancy was found.
  • The results of imaging investigations suggested a bladder-derived tumour (from a bladder diverticulum or persisting urachus).
  • The diagnosis confirmed in histological examination was adenocarcinoma of the colon.
  • The article presents successive stages of diagnosis and therapy.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / pathology. Colonic Neoplasms / diagnosis. Colonic Neoplasms / pathology
  • [MeSH-minor] Aged. Biopsy. Diagnosis, Differential. Humans. Male. Urinary Bladder Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19606709.001).
  • [ISSN] 1426-9686
  • [Journal-full-title] Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
  • [ISO-abbreviation] Pol. Merkur. Lekarski
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


74. Reid-Nicholson MD, Ramalingam P, Adeagbo B, Cheng N, Peiper SC, Terris MK: The use of Urovysion fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder. Mod Pathol; 2009 Jan;22(1):119-27
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The use of Urovysion fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder.
  • We evaluated Urovysion FISH in non-urothelial carcinoma involving bladder to determine its possible application to their diagnosis and surveillance.
  • Paraffin blocks from 31 non-urothelial bladder carcinomas, 12 pure urothelial carcinomas and 2 urothelial carcinomas with squamous differentiation were tested according to Vysis-Abbot Laboratories' recommended standards.
  • Cases included 15 primary squamous carcinoma, 2 urothelial carcinoma with squamous differentiation, 4 primary adenocarcinoma, 5 colonic, 4 prostatic and 1 cervical adenocarcinoma.
  • In conclusion, we found that chromosomal abnormalities tested for by Urovysion FISH may be seen in non-urothelial carcinomas of bladder.
  • These false-positive results were frequent in primary and secondary adenocarcinoma and rare in squamous carcinoma.
  • This has significant implications for the accurate diagnosis and management of patients with urinary tract cancer.
  • Urovysion FISH cannot be used to definitively diagnose squamous carcinoma or adenocarcinoma nor can it be used to differentiate the two from urothelial carcinoma.
  • However, it may be useful as a surveillance tool in established primary and secondary bladder adenocarcinoma.
  • [MeSH-major] In Situ Hybridization, Fluorescence / methods. Urinary Bladder Neoplasms / diagnosis. Urinary Bladder Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18978733.001).
  • [ISSN] 1530-0285
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


75. Yan X, Li G, Shang H, Wang G, Chen L, Han Y: Complications of laparoscopic radical hysterectomy and pelvic lymphadenectomy--experience of 117 patients. Int J Gynecol Cancer; 2009 Jul;19(5):963-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A retrospective study was conducted on LRH + LPL in 117 cases of cervical cancer with International Federation of Gynecology and Obstetrics stages Ib (n = 96) and II a (n = 21) from August 1998 to December 2006.
  • One patient had a common iliac vein laceration that could not be controlled laparoscopically after failing to deal with the injured branch of common iliac vein.
  • One case of stage IIa with a bladder laceration longer than 3 cm was converted to laparotomy during the early stages of the learning curve.
  • Postoperative complications occurred in 38.5% (n = 45) of the patients, including 38 patients with urinary retention who exhibited complete resolution within 6 months by intermittent training and catheterization, 4 with lymphocyst who underwent conservation treatment, 1 with ureteral fistula that was treated by cystoscopic placement of double-J ureteral stents, 1 with mild adynamic bowel obstruction who received conservative management, and 1 with vesicovaginal fistula that was closed by conservative treatment.
  • [MeSH-minor] Adenocarcinoma / complications. Adenocarcinoma / secondary. Adenocarcinoma / surgery. Adolescent. Adult. Aged. Carcinoma, Adenosquamous / complications. Carcinoma, Adenosquamous / secondary. Carcinoma, Adenosquamous / surgery. Carcinoma, Squamous Cell / complications. Carcinoma, Squamous Cell / secondary. Carcinoma, Squamous Cell / surgery. Female. Humans. Middle Aged. Neoplasm Staging. Prognosis. Retrospective Studies. Survival Rate. Treatment Outcome. Young Adult


76. Khan MH, Dooldeniya MD, Shaikh NA: Urothelial adenocarcinoma in a non-functioning bladder. Scand J Urol Nephrol; 2007;41(2):168-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Urothelial adenocarcinoma in a non-functioning bladder.
  • Urinary diversion is a common final outcome in patients with refractory long-term incontinence.
  • It is even more common in young patients with neurogenic bladders and in such cases the bladder is disconnected and left in situ.
  • We present a unique case of adenocarcinoma of the bladder which occurred 31 years following such a diversion procedure.
  • [MeSH-major] Adenocarcinoma / complications. Adenocarcinoma / diagnosis. Postoperative Complications / diagnosis. Urinary Bladder Neoplasms / complications. Urinary Bladder Neoplasms / diagnosis. Urinary Diversion

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17454958.001).
  • [ISSN] 0036-5599
  • [Journal-full-title] Scandinavian journal of urology and nephrology
  • [ISO-abbreviation] Scand. J. Urol. Nephrol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Sweden
  •  go-up   go-down


77. Chertcoff FJ, Emery NC, Villagomez R, Veltri MA, Venditti J, Young P, Ubaldini J: [Pulmonary tumor embolism: Report of two cases]. Rev Med Chil; 2009 Dec;137(12):1613-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Embolismo pulmonar tumoral: Reporte de dos casos.
  • Dyspnea and hypoxemia in a patient with cancer may have several causes, including infections, thromboembolism, metastases, and pulmonary injuries by drugs.
  • We report a 47-year-old female with breast cancer and a 70-year-old male with urinary bladder cancer who were admitted for dyspnea, hypoxemia and pulmonary hypertension.
  • [MeSH-major] Adenocarcinoma / complications. Breast Neoplasms / complications. Neoplastic Cells, Circulating. Prostatic Neoplasms / complications. Pulmonary Embolism / etiology. Urinary Bladder Neoplasms / complications


78. Mazigo HD, Zinga M, Heukelbach J, Rambau P: Case Series of Adenocarcinoma of the Prostate Associated with Schistosoma haematobium Infection in Tanzania. J Glob Infect Dis; 2010 Sep;2(3):307-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Case Series of Adenocarcinoma of the Prostate Associated with Schistosoma haematobium Infection in Tanzania.
  • In endemic areas, schistosomiasis has been associated with the pathogenesis of bladder, prostate, colorectal and renal carcinoma.
  • However, the relationship between prostate cancer and schistosomiasis infection remains controversial.
  • Here we present a series of three cases from Tanzania of prostatic adenocarcinoma associated with urinary schistosomiasis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20927294.001).
  • [ISSN] 0974-8245
  • [Journal-full-title] Journal of global infectious diseases
  • [ISO-abbreviation] J Glob Infect Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2946689
  • [Keywords] NOTNLM ; Adenocarcinoma / Prostate / Schistosoma haematobium / Schistosomiasis / Tanzania
  •  go-up   go-down


79. Li X, Qi X, Zhou L, Fu W, Abdul-Karim FW, Maclennan G, Gorodeski GI: P2X(7) receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin. Purinergic Signal; 2009 Sep;5(3):351-68
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] P2X(7) receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin.
  • The aim of the present study was to better understand the biological significance of P2X(7) receptor expression in normal and cancer human epithelial tissues.
  • P2X(7) receptor and messenger RNA (mRNA) levels were determined in human tissues containing epithelial dysplastic, pre- or early cancerous, and cancer cells, and the levels were compared to those in the corresponding normal epithelial cells within the same tissue of the same case.
  • P2X(7) receptor levels in cancer cells were similar (colon adenocarcinoma) or greater (thyroid papillary carcinoma) than those in the corresponding normal cells.
  • In contrast, in cancer cells of the ectocervix (squamous), endocervix and endometrium (adenocarcinoma), urinary bladder (transitional cell carcinoma), and breast (ductal and lobular adenocarcinomas), P2X(7) receptor levels were lower by about twofold than those in the corresponding normal epithelial cells.
  • Similarly, P2X(7) mRNA levels were lower in uterine, bladder, and breast cancer epithelial tissues by about fourfold than those in the corresponding normal tissues.
  • In addition, P2X(7) receptor levels were decreased already in dysplastic ectocervical cells and pre- or early cancerous endometrial and bladder cells.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Science. 1996 May 3;272(5262):735-8 [8614837.001]
  • [Cites] Breast Cancer Res Treat. 2004 Jan;83(1):1-10 [14997049.001]
  • [Cites] Am J Physiol. 1993 Sep;265(3 Pt 1):C577-606 [8214015.001]
  • [Cites] J Biol Chem. 2008 Oct 17;283(42):28274-86 [18682393.001]
  • [Cites] Endocrinology. 2008 Jan;149(1):389-96 [17947359.001]
  • [Cites] Mol Pharmacol. 2007 Dec;72(6):1447-56 [17785580.001]
  • [Cites] Gynecol Oncol. 2007 Jul;106(1):233-43 [17482244.001]
  • [Cites] FEBS Lett. 2007 Feb 6;581(3):483-8 [17240370.001]
  • [Cites] Curr Pharm Des. 2006;12(34):4411-25 [17168751.001]
  • [Cites] Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1045-9 [17065062.001]
  • [Cites] Semin Cancer Biol. 2006 Oct;16(5):344-7 [16914325.001]
  • [Cites] Cancer Res. 2006 Aug 1;66(15):7386-9 [16885331.001]
  • [Cites] J Biol Chem. 2006 Jun 23;281(25):17228-37 [16624800.001]
  • [Cites] Histopathology. 2004 Mar;44(3):206-15 [14987223.001]
  • [Cites] J Neurosci. 2003 Oct 1;23(26):8903-10 [14523092.001]
  • [Cites] J Invest Dermatol. 2003 Aug;121(2):315-27 [12880424.001]
  • [Cites] Aging Cell. 2003 Feb;2(1):39-45 [12882333.001]
  • [Cites] Melanoma Res. 2003 Apr;13(2):137-45 [12690296.001]
  • [Cites] Cell Physiol Biochem. 2003;13(2):93-102 [12649594.001]
  • [Cites] FEBS Lett. 2003 Mar 13;538(1-3):159-62 [12633871.001]
  • [Cites] J Biol Chem. 2003 Feb 14;278(7):4590-6 [12464620.001]
  • [Cites] Physiol Rev. 2002 Oct;82(4):1013-67 [12270951.001]
  • [Cites] J Biol Chem. 2001 Jun 29;276(26):23262-7 [11313357.001]
  • [Cites] J Biol Chem. 2000 Sep 1;275(35):26792-8 [10854431.001]
  • [Cites] J Urol. 2000 Jun;163(6):2002-7 [10799247.001]
  • [Cites] Oral Oncol. 1999 Nov;35(6):541-7 [10705087.001]
  • [Cites] J Clin Immunol. 1999 Nov;19(6):350-64 [10634209.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):1-2 [16434576.001]
  • [Cites] J Invest Dermatol. 2005 Sep;125(3):482-90 [16117789.001]
  • [Cites] Biochem Biophys Res Commun. 2005 Jun 24;332(1):17-27 [15896293.001]
  • [Cites] Endocrinology. 2005 Jan;146(1):164-74 [15459114.001]
  • [Cites] Endocrinology. 2004 Dec;145(12):5568-79 [15319352.001]
  • [Cites] J Pathol. 1999 Sep;189(1):12-9 [10451482.001]
  • [Cites] J Cell Biol. 1997 Dec 29;139(7):1635-43 [9412459.001]
  • [Cites] Br J Pharmacol. 1999 Aug;127(8):1915-21 [10482924.001]
  • [Cites] Cell Tissue Res. 1999 Jun;296(3):599-605 [10370147.001]
  • [Cites] Cell Biochem Biophys. 1998;29(3):281-306 [9868583.001]
  • [Cites] Receptors Channels. 1998;5(6):347-54 [9826911.001]
  • [Cites] Neurochem Int. 1998 Sep;33(3):209-15 [9759915.001]
  • [Cites] Pharmacol Rev. 1998 Sep;50(3):413-92 [9755289.001]
  • [Cites] Cell Biol Toxicol. 1998 Mar;14(2):111-20 [9553722.001]
  • [Cites] J Immunol. 1997 Aug 1;159(3):1451-8 [9233643.001]
  • [Cites] Physiol Rev. 1997 Apr;77(2):397-424 [9114819.001]
  • [Cites] Annu Rev Cell Biol. 1991;7:663-98 [1809356.001]
  • [Cites] Arch Toxicol. 1991;65(6):437-44 [1929863.001]
  • [Cites] Int Rev Cytol. 1980;68:251-306 [7014501.001]
  • [Cites] J Invest Dermatol. 1972 Sep;59(3):251-9 [5055188.001]
  • [Cites] Am J Physiol. 1995 May;268(5 Pt 1):C1215-26 [7762615.001]
  • (PMID = 19399640.001).
  • [ISSN] 1573-9538
  • [Journal-full-title] Purinergic signalling
  • [ISO-abbreviation] Purinergic Signal.
  • [Language] ENG
  • [Grant] United States / NIA NIH HHS / AG / R01 AG015955
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Other-IDs] NLM/ PMC2717318
  •  go-up   go-down


80. Nikolova M, Stoĭkov S, Kalchev I, Kiuchukov I: [Urachal carcinoma of urinary bladder, simulating ovarial cyst]. Akush Ginekol (Sofiia); 2005;44(7):45-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Urachal carcinoma of urinary bladder, simulating ovarial cyst].
  • [MeSH-major] Adenocarcinoma, Mucinous / diagnosis. Ovarian Cysts / diagnosis. Urachus / ultrasonography. Urinary Bladder Neoplasms / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Laparoscopy. Middle Aged

  • Genetic Alliance. consumer health - Urachal cyst.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cysts.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16544721.001).
  • [ISSN] 0324-0959
  • [Journal-full-title] Akusherstvo i ginekologii︠a︡
  • [ISO-abbreviation] Akush Ginekol (Sofiia)
  • [Language] bul
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Bulgaria
  •  go-up   go-down


81. Gatta G, Ciccolallo L, Kunkler I, Capocaccia R, Berrino F, Coleman MP, De Angelis R, Faivre J, Lutz JM, Martinez C, Möller T, Sankila R, EUROCARE Working Group: Survival from rare cancer in adults: a population-based study. Lancet Oncol; 2006 Feb;7(2):132-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Survival from rare cancer in adults: a population-based study.
  • BACKGROUND: Rare cancers are a challenge to clinical practice, and treatment experience, even in major cancer centres to which rare cancers are usually referred, is often limited.
  • We also estimated the adjusted relative excess risk of death for every rare cancer.
  • FINDINGS: Overall 5-year relative survival was good (ie, >65%) for placental choriocarcinoma (85.4% [95% CI 81.4-89.5]), thyroid medullary carcinoma (72.4% [69.2-75.5]), ovarian germ-cell cancer (73.0% [70.0-76.0]), lung carcinoid (70.1% [67.3-72.9]), and cervical adenocarcinoma (65.5% [64.3-66.6]); intermediate (ie, 35-65%) for testicular cancer at age 65 years or older (64.0% [59.3-68.7]), sarcoma of extremities (60.0% [58.9-61.2]), digestive-system endocrine cancers (55.6% [54.9-56.3]), anal squamous-cell carcinoma (53.1% [51.5-54.8]), and uterine sarcoma (43.5% [42.0-44.9]); low for carcinoma of adrenal-gland cortex (32.7% [28.3-37.2]) and bladder squamous-cell carcinoma (20.4% [18.8-22.0]); and poor for angiosarcoma of liver (6.4% [1.8-11.0]) and mesothelioma (4.7% [4.3-5.2]).
  • Survival significantly improved over time for ovarian germ-cell cancer, sarcomas of extremities, digestive-system endocrine tumours, anal squamous-cell carcinoma, and angiosarcoma of liver.

  • MedlinePlus Health Information. consumer health - Rare Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16455477.001).
  • [ISSN] 1470-2045
  • [Journal-full-title] The Lancet. Oncology
  • [ISO-abbreviation] Lancet Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


82. Justino PB, Baroni R, Blasbalg R, Carvalho Hde A: Clinical tumor dimensions may be useful to prevent geographic miss in conventional radiotherapy of uterine cervix cancer-a magnetic resonance imaging-based study. Int J Radiat Oncol Biol Phys; 2009 Jun 1;74(2):503-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical tumor dimensions may be useful to prevent geographic miss in conventional radiotherapy of uterine cervix cancer-a magnetic resonance imaging-based study.
  • MATERIALS AND METHODS: The study population consisted of 80 patients with uterine cervix cancer seen between 2001 and 2006.
  • Study variables included tumor volume; involvement of vagina, parametrium, bladder, or rectum; posterior displacement of the anterior rectal wall; and tumor anteroposterior diameter (APD).
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / radiotherapy. Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / radiotherapy. Female. Humans. Middle Aged. Rectum / pathology. Statistics, Nonparametric. Young Adult


83. Kefeli M, Gonullu G, Can B, Malatyalioglu E, Kandemir B: Metastasis of adenocarcinoma of the gall bladder to an endometrial polyp detected by endometrial curettage: case report and review of the literature. Int J Gynecol Pathol; 2009 Jul;28(4):343-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasis of adenocarcinoma of the gall bladder to an endometrial polyp detected by endometrial curettage: case report and review of the literature.
  • Breast carcinoma is the most frequent extragenital cancer that metastasizes to the endometrial polyp.
  • We report the case of a 63-year-old with metastatic gall bladder adenocarcinoma involving endometrial polyps detected by endometrial curetting.
  • After this diagnosis, bone metastases were detected during radiologic screening.
  • Gastrointestinal tumor metastasis to an endometrial polyp is a very rare event, but if a patient with a known primary extragenital tumor has abnormal vaginal bleeding, the possibility of metastasis should be included in the differential diagnosis.
  • [MeSH-major] Adenocarcinoma / secondary. Endometrial Neoplasms / secondary. Gallbladder Neoplasms / pathology. Polyps / pathology

  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19483630.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 24
  •  go-up   go-down


84. Shrestha BM, Prasopshanti K, Matanhelia SS, Peeling WB: Blood loss during and after transurethral resection of prostate: a prospective study. Kathmandu Univ Med J (KUMJ); 2008 Jul-Sep;6(23):329-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: Transurethral resection of prostate (TURP) is the gold standard treatment for symptomatic prostatic bladder outlet obstruction.
  • The median intraoperative (SA: 89.95 (5-936); GA: 105.40 (5-517) mls), postoperative (SA: 72.37 (15-387); GA: 136.43 (11-969) mls) and total (SA: 162.32 (29-1200); GA: 241.83 (21-1251) mls) blood losses were not significantly different between the two groups (95% C.I.
  • Of these, 3 patients required blood transfusion as compared to 1 patient in rest of the group, although this was not statistically significant (95% C.I - 67.2 to 1120.4, p = 0.87).
  • CONCLUSIONS: The intraoperative, postoperative and total blood losses related to TURP were not influenced by the type of anaesthesia, resection time, weight of the resected prostate and the histology.
  • [MeSH-minor] Adenocarcinoma / surgery. Aged. Aged, 80 and over. Aspirin / therapeutic use. Blood Volume. Cohort Studies. Humans. Male. Middle Aged. Platelet Aggregation Inhibitors / therapeutic use. Prospective Studies. Prostatic Hyperplasia / surgery. Prostatic Neoplasms / surgery. Prostatitis / surgery. Urinary Catheterization. Urinary Tract Infections / complications

  • Hazardous Substances Data Bank. ACETYLSALICYLIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20071814.001).
  • [ISSN] 1812-2078
  • [Journal-full-title] Kathmandu University medical journal (KUMJ)
  • [ISO-abbreviation] Kathmandu Univ Med J (KUMJ)
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Nepal
  • [Chemical-registry-number] 0 / Platelet Aggregation Inhibitors; R16CO5Y76E / Aspirin
  •  go-up   go-down


85. Sachedina N, De Los Santos R, Manoharan M, Soloway MS: Total prostatectomy and lymph node dissection may be done safely without pelvic drainage: an extended experience of over 600 cases. Can J Urol; 2009 Aug;16(4):4721-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • From our experience with 846 patients, we contend that patient safety and efficacy is not compromised by selectively omitting a pelvic drain.
  • MATERIALS AND METHODS: TP/LND was performed in 846 patients with clinically localized prostate adenocarcinoma.
  • After the prostate was removed and the anastomotic sutures tied, saline was instilled into the bladder through the urethral catheter.
  • When comparing the incidence of urinary retention, hematuria, anastomotic stricture, pelvic fluid collections, hematuria, and thrombolic events, there was no significant difference between patients with and without a drain.
  • [MeSH-major] Adenocarcinoma / surgery. Lymph Node Excision / methods. Prostatectomy / methods. Prostatic Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19671222.001).
  • [ISSN] 1195-9479
  • [Journal-full-title] The Canadian journal of urology
  • [ISO-abbreviation] Can J Urol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Canada
  •  go-up   go-down


86. Soares MJ, Neves T, Covita A, Monteiro P, Canhoto A, Nogueira R, Barreto JL, Mendonça JC, Maya M, Monteiro H: [Bladder adenocarcinoma. Case report]. Arch Esp Urol; 2008 Sep;61(7):828-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bladder adenocarcinoma. Case report].
  • [Transliterated title] Adenocarcinoma vesical. Aportación de un caso clínico.
  • OBJECTIVE: Primary bladder adenocarcinoma is a rare entity.
  • METHOD/RESULTS: A 74 year old female patient presents to the emergency department with complaints of gross hematúria not accompanied by lower urinary tract symptoms.
  • Diagnostic work-up included renal and bladder ultrasound, cistoscopy and abdomino-pelvic C. T. scan.
  • Trans-urethral resection revealed an invasive adenocarcinoma.
  • The bladder specimen showed primary bladder adenocarcinoma, pT3aNO.
  • At 6 months of follow-up, the patient does not present disease progression or surgical complications.
  • CONCLUSION: Primary bladder adenocarcinoma is rare.
  • [MeSH-major] Adenocarcinoma. Urinary Bladder Neoplasms

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18972921.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 17
  •  go-up   go-down


87. Martínez-Cornelio A, Flores-López D, Ojeda RF, Quintero-Becerra J, Hernández-Toriz N: [Surgical experience with urachal carcinoma]. Cir Cir; 2009 Jan-Feb;77(1):33-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Experiencia quirúrgica en el adenocarcinoma de uraco.
  • BACKGROUND: Urachal carcinomas are rare neoplasms that constitute <1% of bladder tumors.
  • Clinical files were reviewed of patients with diagnosis of bladder cancer and who were operated on with radical cystectomy with urinary substitution and extended partial cystectomy, selecting those patients with pathological report of urachal carcinoma.
  • RESULTS: Of the 306 patients operated on with radical surgery for bladder cancer, only five patients (1.6%) had a diagnosis of urachal carcinoma.
  • In the other four cases, tumor was reported in the dome of the bladder and for this reason cystoscopy and transurethral resection of the bladder (TURB) were done, confirming the clinical findings in addition to the pathology report suggesting urachal carcinoma.
  • This was the reason for the Studer-type orthotopic bladder substitution.
  • Symptoms in most cases are similar to those of bladder pathology origin.
  • [MeSH-major] Adenocarcinoma / surgery. Urachus. Urinary Bladder Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19344561.001).
  • [ISSN] 0009-7411
  • [Journal-full-title] Cirugía y cirujanos
  • [ISO-abbreviation] Cir Cir
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


88. Mori H, Ohno Y, Ito F, Funaguchi N, Yanase K, Endo J, Nakano M, Bai La BL, Minatoguchi S: Massive hematuria from the bilateral upper urinary tract in a patient treated for advanced lung cancer with gefitinib. Jpn J Clin Oncol; 2010 Mar;40(3):263-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Massive hematuria from the bilateral upper urinary tract in a patient treated for advanced lung cancer with gefitinib.
  • We report a case of gefitinib-induced bilateral upper urinary tract bleeding in an 82-year-old woman administered the drug daily for advanced non-small cell adenocarcinoma of the lung (T4N3M0).
  • Cystoscopy revealed bleeding from the bilateral ureteric orifices without hemorrhagic inflammation of the bladder.
  • Instead, the reproducibility of the hematuria from the upper urinary system strongly suggests an unexpected gefitinib-related adverse effect.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Agents / adverse effects. Hematuria / chemically induced. Lung Neoplasms / drug therapy. Quinazolines / adverse effects. Urinary Tract / drug effects

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19897850.001).
  • [ISSN] 1465-3621
  • [Journal-full-title] Japanese journal of clinical oncology
  • [ISO-abbreviation] Jpn. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Quinazolines; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; S65743JHBS / gefitinib
  •  go-up   go-down


89. Huang Y, Tian XF, Fan XG, Fu CY, Zhu C: The pathological effect of Helicobacter pylori infection on liver tissues in mice. Clin Microbiol Infect; 2009 Sep;15(9):843-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Helicobacter pylori infection is associated with chronic gastritis, peptic ulcer, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma.
  • In this study, the pathological changes in the liver and gall bladder in H. pylori-colonized C57BL/6 mice were investigated.
  • The gall bladder mucosa of one H. pylori-infected mouse showed thickening of the mucous membrane with mild submucosal lymphocytic infiltration. H. pylori was observed morphologically in four liver specimens and six gall bladders from infected mice by immunohistochemistry.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • MedlinePlus Health Information. consumer health - Hepatitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19392901.001).
  • [ISSN] 1469-0691
  • [Journal-full-title] Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • [ISO-abbreviation] Clin. Microbiol. Infect.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / DNA, Bacterial
  •  go-up   go-down


90. Abd El Gawad IA, Moussa HS, Nasr MI, El Gemae EH, Masooud AM, Ibrahim IK, El Hifnawy NM: Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer. J Egypt Natl Canc Inst; 2005 Sep;17(3):193-202
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer.
  • PURPOSE: The diagnostic efficacy of Nuclear Matrix Protein-22 (NMP-22), bladder tumor antigen (BTA TRAK), and telomerase activity was evaluated in urine in a trial to assess their value in the detection of bladder cancer and to compare it to that of routine urine cytology.
  • SUBJECTS AND METHODS: The study included 46 newly diagnosed bladder cancer patients, diagnosed by cystoscopy and histopathological typing, in addition to 20 patients with benign bladder lesions and 20 healthy age and sex matched volunteers as a control group.
  • Fifty percent of the cancer patients (23/46) had proven bilharzial history.
  • Most patients (27/46) had transitional cell carcinoma (TCC), 17/46 had squamous cell carcinoma (SCC), while only 2 patients had adenocarcinoma.
  • For bilharzial cancer bladder respective sensitivities were 69.6%, 95.6%, 100% and 73.9%, while for nonbilharzial cancer bladder the respective sensitivities were 39.1%, 87%, 100% and 87%.
  • CONCLUSION: BTA showed the highest sensitivity in all the studied parameters in the bladder cancer group, bilharzial bladder cancer subgroup, and non bilharzial bladder subgroup, (100%), while the highest specificity was recorded with urine cytology (100%), followed by telomerase (95%), then BTA (92.5%), and lastly NMP- 22 (87.5%).
  • [MeSH-major] Antigens, Neoplasm / urine. Biomarkers, Tumor / urine. Nuclear Proteins / urine. Telomerase / urine. Urinary Bladder Neoplasms / diagnosis. Urinary Bladder Neoplasms / urine
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / urine. Adult. Aged. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / urine. Carcinoma, Transitional Cell / diagnosis. Carcinoma, Transitional Cell / urine. Female. Humans. Male. Middle Aged. Schistosomiasis haematobia / complications

  • Genetic Alliance. consumer health - Bladder cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16799657.001).
  • [ISSN] 1110-0362
  • [Journal-full-title] Journal of the Egyptian National Cancer Institute
  • [ISO-abbreviation] J Egypt Natl Canc Inst
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Egypt
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / Nuclear Proteins; 0 / bladder tumor-associated antigen; 0 / nuclear matrix protein 22; EC 2.7.7.49 / Telomerase
  •  go-up   go-down


91. Brock M, Martin W, Sommerer F, Noldus J: [Ductal Adenocarcinoma of the prostate with infiltration of the bladder. Can radical cystectomy and antiandrogen therapy cure the disease?]. Urologe A; 2009 Jul;48(7):770-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Ductal Adenocarcinoma of the prostate with infiltration of the bladder. Can radical cystectomy and antiandrogen therapy cure the disease?].
  • Ductal adenocarcinoma of the prostate is a rare entity.
  • The lack of correlation between the prostate-specific antigen value and the tumor stage, as well as early dissemination, are major differences from acinar cancer.
  • Urinary obstruction and hematuria lead to clinical assessment.
  • We report the case of a 64-year-old man with ductal prostate cancer who underwent radical cystectomy followed by androgen deprivation therapy.
  • [MeSH-major] Androgen Antagonists / administration & dosage. Carcinoma, Ductal / secondary. Carcinoma, Ductal / therapy. Cystectomy / methods. Prostatic Neoplasms / therapy. Urinary Bladder Neoplasms / secondary. Urinary Bladder Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Clin Pract Urol. 2008 Jan;5(1):55-8 [18185514.001]
  • [Cites] Cancer. 1967 Oct;20(10):1715-22 [4168340.001]
  • [Cites] Cancer. 1991 Apr 15;67(8):2118-24 [2004331.001]
  • [Cites] Am J Surg Pathol. 1985 Aug;9(8):595-609 [4091189.001]
  • [Cites] Am J Clin Pathol. 2006 Aug;126(2):302-9 [16891207.001]
  • [Cites] Cancer. 2007 May 15;109(10):2011-5 [17420979.001]
  • [Cites] J Urol. 2005 Dec;174(6):2186-90 [16280761.001]
  • [Cites] Cancer. 1976 May;37(5):2255-62 [130969.001]
  • [Cites] Am J Surg Pathol. 1999 Dec;23(12):1471-9 [10584700.001]
  • [Cites] Urol Oncol. 2007 Jan-Feb;25(1):53-5 [17208139.001]
  • [Cites] Adv Anat Pathol. 2006 Jan;13(1):57-9 [16462155.001]
  • [Cites] BJU Int. 2008 Nov;102(10):1369-74 [18793296.001]
  • [Cites] Semin Diagn Pathol. 1988 Aug;5(3):301-11 [2845546.001]
  • (PMID = 19352617.001).
  • [ISSN] 1433-0563
  • [Journal-full-title] Der Urologe. Ausg. A
  • [ISO-abbreviation] Urologe A
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Androgen Antagonists
  •  go-up   go-down


92. Flaig TW, La Rosa FG, McKinney K, Maroni P, Wilson S: A man with changes in the urinary bladder: benign metaplasia or adenocarcinoma? Oncology (Williston Park); 2009 Feb;23(2):177-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A man with changes in the urinary bladder: benign metaplasia or adenocarcinoma?
  • [MeSH-major] Adenocarcinoma / diagnosis. Cystitis / diagnosis. Kidney Neoplasms / diagnosis. Lymphatic Diseases / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male. Metaplasia. Nephrolithiasis / complications. Referral and Consultation

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Lymphatic Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19323300.001).
  • [ISSN] 0890-9091
  • [Journal-full-title] Oncology (Williston Park, N.Y.)
  • [ISO-abbreviation] Oncology (Williston Park, N.Y.)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


93. Smeulders N, Sudhakaran N, Wilcox DT, Ransley PG: Adenocarcinoma at the ureterosigmoidostomy site in a 16-year-old demonstrates the importance of screening in children. J Pediatr Urol; 2008 Jun;4(3):234-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma at the ureterosigmoidostomy site in a 16-year-old demonstrates the importance of screening in children.
  • We report the death of a 17-year-old male exstrophy patient from adenocarcinoma arising at the ureterosigmoidostomy.
  • [MeSH-major] Adenocarcinoma / etiology. Bladder Exstrophy / surgery. Colon, Sigmoid / surgery. Colonic Neoplasms / etiology. Ureterostomy / adverse effects
  • [MeSH-minor] Adolescent. Anastomosis, Surgical / adverse effects. Colectomy / methods. Cystectomy / adverse effects. Cystectomy / methods. Diagnosis, Differential. Fatal Outcome. Humans. Male. Postoperative Complications. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18631934.001).
  • [ISSN] 1873-4898
  • [Journal-full-title] Journal of pediatric urology
  • [ISO-abbreviation] J Pediatr Urol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


94. Nasr E, Merhej S, Nehme Nasr D, Fares G, Moukarzel M, Chalouhi E, Bulbul M, Sarkis P, Nemr E, Jabbour M, Khoury R, Ghazale G, Chehade G, Ghosn M, Chahine G, Abillamah A: [A five-year experience in conformational radiotherapy in the treatment of prostate cancer. Evaluation of acute toxicity in 131 patients]. Prog Urol; 2005 Feb;15(1):36-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A five-year experience in conformational radiotherapy in the treatment of prostate cancer. Evaluation of acute toxicity in 131 patients].
  • [Transliterated title] Radiothérapie conformationnelle dans le traitement du cancer de la prostate. Evaluation de la toxicité aiguë chez 131 patients.
  • PURPOSE: To evaluate the urinary and rectal toxicity secondary to 3D conformal radiotherapy for prostate cancer.
  • MATERIAL AND METHODS: Between 1998 and 2003, 131 men with prostate cancer underwent 3D conformal radiotherapy with or without androgen deprivation.
  • The percentage of volume receiving more than 50 Gy (V50) was calculated, the median V50 was 32% (5-67) for the rectum and 35% (5-79) for the bladder CONCLUSION: The toxicity profile in this study is in the same range than those of the literature and of our previous study concerning our first 50 patients with prostate cancer treated with 3D conformal radiotherapy.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Prostatic Neoplasms / radiotherapy. Radiotherapy, Conformal / adverse effects

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15822389.001).
  • [ISSN] 1166-7087
  • [Journal-full-title] Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
  • [ISO-abbreviation] Prog. Urol.
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


95. Ueda Y, Suzuki T, Jun Q, Higuchi Y, Maruyama T, Kondoh N, Nojima M, Yamamoto S, Yamamoto H, Kokura K, Shincho M, Hirota S, Shima H: [An adenocarcinoma arising from the urinary bladder 37 years after bladder augmentation using the ileum]. Hinyokika Kiyo; 2009 Mar;55(3):145-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [An adenocarcinoma arising from the urinary bladder 37 years after bladder augmentation using the ileum].
  • A 57-year-old man had undergone right nephrectomy at 10 years of age and bladder augmentation using the ileum at 20 years for treatment of urinary tract tuberculosis.
  • Cystoscopy revealed a lobulated tumor in the bladder.
  • Transurethral resection of bladder tumor was performed, but complete resection was difficult.
  • Histopathological examination of the specimen revealed a well differentiated adenocarcinoma.
  • The tumor arose from the bladder wall near the anastomotic site between the bladder and the ileal segment.
  • Histopathological examination revealed a well differentiated adenocarcinoma infiltrating into the muscle layer (pT2a).
  • This is the 19th case of adenocarcinoma following bladder augmentation using the ileum reported in the Japanese literature.
  • [MeSH-major] Adenocarcinoma / etiology. Urinary Bladder / surgery. Urinary Bladder Neoplasms / etiology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19378826.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 11
  •  go-up   go-down


96. Prout GR Jr, Wesley MN, Yancik R, Ries LA, Havlik RJ, Edwards BK: Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer; 2005 Oct 15;104(8):1638-47
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study.
  • BACKGROUND: Bladder carcinoma often occurs in older patients who also may have other comorbid conditions that could influence the administration of surgical therapy.
  • The current study was conducted to describe the distribution of comorbid conditions in patients with bladder carcinoma and ascertain whether these conditions, as grouped by the American Society of Anesthesiologists physical status classification, affected the choice of surgical therapy.
  • METHODS: The authors examined six population-based cancer registries from the National Cancer Institute's Surveillance, Epidemiology, and End Results Program in 1992.
  • A random sample of newly diagnosed bladder carcinoma patients were stratified according to registry, age group (ages 55-64 yrs, ages 65-74 yrs, and age 75 yrs and older), and gender.
  • Data regarding comorbid conditions were abstracted from the medical records and merged with routinely collected cancer registry data.
  • [MeSH-major] Aging / physiology. Comorbidity. Urinary Bladder Neoplasms / surgery
  • [MeSH-minor] Adenocarcinoma / surgery. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / surgery. Carcinoma, Transitional Cell / surgery. Cystectomy. Female. Humans. Male. Middle Aged. Neoplasm Invasiveness / pathology. Neoplasm Staging. Prognosis. SEER Program. Survival Rate. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Seniors' Health.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 American Cancer Society
  • [CommentIn] Cancer. 2005 Oct 15;104(8):1563-6 [16116607.001]
  • [CommentIn] Cancer. 2005 Oct 15;104(8):1559-62 [16118803.001]
  • (PMID = 16130136.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Ghoneim MA, Abdel-Latif M, el-Mekresh M, Abol-Enein H, Mosbah A, Ashamallah A, el-Baz MA: Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol; 2008 Jul;180(1):121-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later.
  • PURPOSE: We performed a critical analysis of the results of radical cystectomy for invasive bladder carcinoma treated at 1 center.
  • MATERIALS AND METHODS: Between 1970 and 2000, 2,090 men and 630 women with invasive bladder cancer were treated with 1-stage radical cystectomy and urinary diversion.
  • Squamous tumors accounted for 49.4% of cases, transitional cell carcinoma for 36.4% and adenocarcinoma for 9.6%.
  • [MeSH-major] Carcinoma, Transitional Cell / surgery. Cystectomy. Urinary Bladder Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Urol. 2008 Jul;180(1):12-3 [18485379.001]
  • (PMID = 18485392.001).
  • [ISSN] 1527-3792
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


98. Polychronidis A, Tsaroucha AK, Perente S, Giatromanolaki A, Koukourakis M, Simopoulos C: Port-site metastasis of extrahepatic bile duct carcinoma after laparoscopic cholecystectomy without evidence of a primary tumour. Acta Chir Belg; 2008 Nov-Dec;108(6):768-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • No malignancy was observed in the resected gall-bladder and the patient exhibited a good postoperative course.
  • [MeSH-major] Adenocarcinoma / secondary. Bile Duct Neoplasms / pathology. Bile Duct Neoplasms / surgery. Bile Ducts, Extrahepatic. Cholecystectomy, Laparoscopic / adverse effects. Neoplasm Seeding

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19241938.001).
  • [ISSN] 0001-5458
  • [Journal-full-title] Acta chirurgica Belgica
  • [ISO-abbreviation] Acta Chir. Belg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


99. Ferrari A, Botrugno I, Bombelli E, Dominioni T, Cavazzi E, Dionigi P: Colonoscopy is mandatory after Streptococcus bovis endocarditis: a lesson still not learned. Case report. World J Surg Oncol; 2008;6:49
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colonoscopy is mandatory after Streptococcus bovis endocarditis: a lesson still not learned. Case report.
  • BACKGROUND: Even though the relationship between certain bacterial infections and neoplastic lesions of the colon is well-recognized, this knowledge has not been sufficiently translated into routine practice yet.
  • Preoperative colonoscopy, staging exams and subsequent surgery demonstrated a stenotic adenocarcinoma of the sigmoid colon, invading the left urinary tract and the homolateral bladder wall, with regional lymph nodes involvement and massive bilobar liver metastases (T4N1M1).
  • After Hartmann's rectosigmoidectomy and despite systemic chemotherapy, a rapid progression occurred and the patient survived for only 5 months after diagnosis.
  • Five years before detecting this advanced colonic cancer, the patient underwent aortic valve replacement due to a severe Streptococcus bovis endocarditis.
  • CONCLUSION: As this case illustrates, in the unusual setting of a Streptococcus bovis infection, it is necessary to timely and carefully rule out occult colon cancer and other malignancies during hospitalization and, if a tumor is not found, to schedule endoscopic follow-up.
  • Rigorous application of these recommendations in the case described would have likely led to an earlier diagnosis of cancer and maybe saved the patient's life.
  • [MeSH-major] Colonic Neoplasms / diagnosis. Colonoscopy. Endocarditis, Bacterial / etiology. Streptococcal Infections / etiology. Streptococcus bovis

  • Genetic Alliance. consumer health - Endocarditis.
  • MedlinePlus Health Information. consumer health - Colonoscopy.
  • MedlinePlus Health Information. consumer health - Streptococcal Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Surg. 1990 Jun;211(6):786-91; discussion 791-2 [2357141.001]
  • [Cites] Eur Heart J. 1995 Dec;16(12):1975-80 [8682035.001]
  • [Cites] J Laryngol Otol. 1997 Jul;111(7):666-8 [9282212.001]
  • [Cites] J Clin Pathol. 1998 Jun;51(6):473-4 [9771449.001]
  • [Cites] J Med Assoc State Ala. 1951 Dec;21(6):162-6 [14880846.001]
  • [Cites] Clin Infect Dis. 2005 Apr 1;40(7):1070-1 [15825011.001]
  • [Cites] Dis Colon Rectum. 2006 Aug;49(8):1223-7 [16845563.001]
  • [Cites] Int J Cancer. 2006 Nov 1;119(9):2127-35 [16841330.001]
  • [Cites] Singapore Med J. 2007 Feb;48(2):e43-5 [17304377.001]
  • [Cites] Dig Dis Sci. 2007 Sep;52(9):2336-9 [17443405.001]
  • [Cites] Carcinogenesis. 2000 Apr;21(4):753-6 [10753212.001]
  • [Cites] Rheumatology (Oxford). 2000 Mar;39(3):338-9 [10788550.001]
  • [Cites] Int J Syst Evol Microbiol. 2003 May;53(Pt 3):631-45 [12807180.001]
  • [Cites] Clin Infect Dis. 2004 May 15;38(10):1394-400 [15156477.001]
  • [Cites] Arch Surg. 2004 Jul;139(7):760-5 [15249410.001]
  • [Cites] Ann Surg. 1974 Feb;179(2):190-1 [4204268.001]
  • [Cites] N Engl J Med. 1977 Oct 13;297(15):800-2 [408687.001]
  • [Cites] N Engl J Med. 1977 Dec 15;297(24):1354-5 [917098.001]
  • [Cites] Ann Intern Med. 1979 Oct;91(4):560-2 [484953.001]
  • [Cites] JAMA. 1981 Jan 23-30;245(4):360-3 [7452862.001]
  • [Cites] Am J Gastroenterol. 1983 Mar;78(3):162-3 [6829536.001]
  • [Cites] J Clin Microbiol. 1989 Feb;27(2):305-8 [2915024.001]
  • (PMID = 18474093.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2397406
  •  go-up   go-down


100. Del Sordo R, Bellezza G, Colella R, Mameli MG, Sidoni A, Cavaliere A: Primary signet-ring cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 5 cases. Appl Immunohistochem Mol Morphol; 2009 Jan;17(1):18-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary signet-ring cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 5 cases.
  • Primary signet-ring cell carcinoma of the urinary bladder is a rare histologic variant of adenocarcinoma.
  • Generally, this neoplasm occurs in middle age and the clinical presentation does not differ from the most frequent transitional cell carcinomas.
  • The prognosis is frequently poor as at diagnosis it is often in an advanced phase.
  • We present 5 cases of primary signet-ring cell carcinoma of the urinary bladder and we used a panel of histochemical and immunohistochemical markers for differential diagnosis from secondary carcinoma in an attempt to elucidate the histogenetic derivation of this neoplasia.

  • Genetic Alliance. consumer health - Signet ring cell carcinoma.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18698262.001).
  • [ISSN] 1533-4058
  • [Journal-full-title] Applied immunohistochemistry & molecular morphology : AIMM
  • [ISO-abbreviation] Appl. Immunohistochem. Mol. Morphol.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down






Advertisement